≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm: Connective and other soft tissue, unspecified

MESH Endpoint Browser

CD2_BENIGN_CONNSOFT_NOS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D21.9&
  • Hospital discharge: ICD-9 — 215[8-9]
  • Hospital discharge: ICD-8 — 2150[5|9]
  • Cause of death: ICD-10 — D21.9&
  • Cause of death: ICD-9 — 215[8-9]
  • Cause of death: ICD-8 — 2150[5|9]

2 out of 7 registries used, show all original rules.

450

4. Check minimum number of events

None

450

5. Include endpoints

None

450

6. Filter based on genotype QC (FinnGen only)

435

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D21
Name in latin
Neoplasma benignum textus connectivi sive alterius textus mollis non specificatum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 435 268 167
Unadjusted period prevalence (%) 0.09 0.10 0.08
Median age at first event (years) 50.99 49.42 53.50

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
450
Matched controls
4500
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D21.9
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue, unspecified
12244.4
307.7
366
*
21509
ICD-8 Finland
Other benign neoplasm of muscular and connective tissue, Unspecified
+∞
61.9
58
*
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
21.5
56.1
43
22
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
10.1
29.2
34
36
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
7.4
20.2
30
43
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
5.0
15.4
34
72
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.7
15.0
51
151
2159X
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Site unspecified
+∞
14.7
14
*
D21.2
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of lower limb, including hip
37.4
14.5
18
5
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
15.1
14.2
23
16
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
5.8
13.5
25
45
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
15.2
11.9
19
13
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.6
11.5
22
41
NDR30
NOMESCO Finland
Complete excision of soft tissue tumour of wrist or hand
41.0
10.0
12
*
NHR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of ankle or foot
30.7
9.4
12
*
NDM99
NOMESCO Finland
Other operation on fascia, ganglion, synovial sheath or bursa of wrist or hand
13.3
7.9
13
10
S18
ICPC
Laceration/cut
1.7
7.5
221
1612
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.6
7.2
44
183
D17.0
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
6.6
6.7
16
25
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
3.4
6.7
24
74
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
18.3
6.3
9
5
21505
ICD-8 Finland
Other benign neoplasm of muscular and connective tissue, Loco multiplici
+∞
6.3
6
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
6.1
85
492

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Outpatient Visit
OP [9202]
1.2e-01
4.9e-01
8.4e-01
6.2e+00
1.3e+00
9.5e-01
6.8e-01
cases:65.16%
controls:62.43%
cases:54.39%
controls:42.09%
cases:18.80%
controls:9.09%
cases:61.65%
controls:0.33%
cases:25.69%
controls:8.31%
cases:64.68%
controls:41.47%
cases:83.24%
controls:71.62%
260
2459
139
1480
217
1658
182
2281
75
358
324
3581
246
13
153
3926
102
327
295
3608
249
1589
136
2243
298
2521
60
999
Hand Surgery
40 [38004480]
8.2e-01
2.0e+00
—
1.0e+50
3.1e+00
2.7e+00
1.3e+00
cases:4.76%
controls:2.16%
cases:4.76%
controls:0.69%
—
—
cases:15.29%
controls:0.00%
cases:2.77%
controls:0.13%
cases:11.95%
controls:0.89%
cases:8.10%
controls:2.33%
19
85
380
3854
19
27
380
3912
—
61
0
338
3939
11
5
386
3930
46
34
339
3798
29
82
329
3438
Plastic And Reconstructive Surgery
24 [38004467]
4.5e-01
1.8e+00
3.0e+00
1.0e+50
—
3.1e+00
1.0e+00
cases:3.51%
controls:2.26%
cases:6.02%
controls:1.02%
cases:2.51%
controls:0.13%
cases:15.29%
controls:0.00%
—
—
cases:14.29%
controls:0.73%
cases:6.42%
controls:2.36%
14
89
385
3850
24
40
375
3899
10
5
389
3934
61
0
338
3939
—
55
28
330
3804
23
83
335
3437
Removal of sutures
SPAT1153 [2001700254]
3.3e-02
4.8e-01
2.1e+00
—
2.7e+00
1.4e+00
7.4e-01
cases:4.01%
controls:3.88%
cases:2.01%
controls:1.24%
cases:1.50%
controls:0.18%
—
—
cases:2.27%
controls:0.15%
cases:4.68%
controls:1.20%
cases:8.38%
controls:4.18%
16
153
383
3786
8
49
391
3890
6
7
393
3932
—
9
6
388
3929
18
46
367
3786
30
147
328
3373
Ganglion
M67.4 [45582222]
—
2.7e+00
—
—
—
2.6e+00
1.5e+00
—
—
cases:3.01%
controls:0.20%
—
—
—
—
—
—
cases:1.82%
controls:0.13%
cases:2.79%
controls:0.65%
—
12
8
387
3931
—
—
—
7
5
378
3827
10
23
348
3497
General Surgery
2 [38004447]
2.0e-01
9.6e-01
1.8e+00
1.0e+50
3.0e+00
8.6e-01
4.6e-01
cases:20.55%
controls:17.49%
cases:12.03%
controls:4.98%
cases:4.51%
controls:0.81%
cases:28.57%
controls:0.00%
cases:8.56%
controls:0.46%
cases:11.95%
controls:5.43%
cases:20.95%
controls:14.38%
82
689
317
3250
48
196
351
3743
18
32
381
3907
114
0
285
3939
34
18
363
3917
46
208
339
3624
75
506
283
3014
Upper gastrointestinal surgery
106 [44777669]
4.6e-01
1.2e+00
2.4e+00
—
2.5e+00
7.7e-01
5.2e-01
cases:10.03%
controls:6.60%
cases:7.52%
controls:2.36%
cases:2.26%
controls:0.20%
—
—
cases:3.27%
controls:0.28%
cases:5.71%
controls:2.74%
cases:12.57%
controls:7.87%
40
260
359
3679
30
93
369
3846
9
8
390
3931
—
13
11
384
3924
22
105
363
3727
45
277
313
3243
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
D48.1 [45566694]
-1.0e+50
3.2e+00
1.0e+50
—
1.0e+50
—
2.8e+00
cases:0.00%
controls:0.18%
cases:3.01%
controls:0.13%
cases:2.01%
controls:0.00%
—
—
cases:2.52%
controls:0.00%
—
—
cases:2.79%
controls:0.17%
0
7
399
3932
12
5
387
3934
8
0
391
3939
—
10
0
387
3935
—
10
6
348
3514
General anesthesia, balanced
WX408 [2001310808]
2.5e-01
6.2e-01
—
1.0e+50
2.5e+00
1.7e+00
1.1e+00
cases:3.76%
controls:2.94%
cases:1.50%
controls:0.81%
—
—
cases:1.50%
controls:0.00%
cases:1.51%
controls:0.13%
cases:3.38%
controls:0.63%
cases:5.03%
controls:1.79%
15
116
384
3823
6
32
393
3907
—
6
0
393
3939
6
5
391
3930
13
24
372
3808
18
63
340
3457
Outpatient Hospital
22 [8756]
2.5e-01
2.2e-01
1.7e+00
1.0e+50
2.0e+00
9.9e-01
4.8e-01
cases:26.82%
controls:22.19%
cases:8.52%
controls:6.98%
cases:3.76%
controls:0.69%
cases:9.77%
controls:0.00%
cases:5.04%
controls:0.69%
cases:14.81%
controls:6.08%
cases:25.42%
controls:17.41%
107
874
292
3065
34
275
365
3664
15
27
384
3912
39
0
360
3939
20
27
377
3908
57
233
328
3599
91
613
267
2907
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
1.5e-01
4.9e-02
2.2e+00
—
2.0e+00
9.9e-01
5.0e-01
cases:6.52%
controls:5.69%
cases:3.01%
controls:2.87%
cases:1.75%
controls:0.20%
—
—
cases:1.76%
controls:0.25%
cases:5.71%
controls:2.19%
cases:13.41%
controls:8.61%
26
224
373
3715
12
113
387
3826
7
8
392
3931
—
7
10
390
3925
22
84
363
3748
48
303
310
3217
Inpatient Hospital
21 [8717]
1.3e-01
2.8e-01
1.5e+00
—
2.1e+00
8.8e-01
4.9e-01
cases:32.08%
controls:29.30%
cases:12.53%
controls:9.80%
cases:4.51%
controls:1.02%
—
—
cases:7.05%
controls:0.94%
cases:19.22%
controls:9.00%
cases:31.84%
controls:22.27%
128
1154
271
2785
50
386
349
3553
18
40
381
3899
—
28
37
369
3898
74
345
311
3487
114
784
244
2736
One hour or less
ZXE00 [2001311394]
4.2e-01
9.6e-01
2.1e+00
1.0e+50
—
1.8e+00
7.5e-01
cases:7.52%
controls:5.05%
cases:3.76%
controls:1.47%
cases:1.50%
controls:0.18%
cases:1.50%
controls:0.00%
—
—
cases:6.75%
controls:1.15%
cases:7.54%
controls:3.69%
30
199
369
3740
15
58
384
3881
6
7
393
3932
6
0
393
3939
—
26
44
359
3788
27
130
331
3390
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
9.7e-02
3.6e-01
1.0e+00
2.4e+00
9.8e-01
3.9e-01
3.2e-01
cases:21.30%
controls:19.73%
cases:18.05%
controls:13.35%
cases:5.51%
controls:2.06%
cases:2.26%
controls:0.20%
cases:4.53%
controls:1.75%
cases:18.96%
controls:13.65%
cases:39.66%
controls:32.24%
85
777
314
3162
72
526
327
3413
22
81
377
3858
9
8
390
3931
18
69
379
3866
73
523
312
3309
142
1135
216
2385
Laceration/cut
S18 [2002000983]
8.3e-02
3.0e-01
1.3e+00
—
2.6e+00
1.1e+00
5.8e-01
cases:5.76%
controls:5.33%
cases:2.76%
controls:2.06%
cases:1.25%
controls:0.33%
—
—
cases:2.77%
controls:0.20%
cases:5.71%
controls:2.01%
cases:12.57%
controls:7.47%
23
210
376
3729
11
81
388
3858
5
13
394
3926
—
11
8
386
3927
22
77
363
3755
45
263
313
3257
Laboratory Visit
OMOP4822461 [32036]
7.1e-02
2.3e-01
6.7e-01
2.9e+00
7.3e-01
1.8e-01
6.1e-02
cases:31.33%
controls:29.83%
cases:32.58%
controls:27.77%
cases:15.04%
controls:8.28%
cases:8.02%
controls:0.48%
cases:14.86%
controls:7.78%
cases:34.29%
controls:30.40%
cases:49.44%
controls:47.93%
125
1175
274
2764
130
1094
269
2845
60
326
339
3613
32
19
367
3920
59
306
338
3629
132
1165
253
2667
177
1687
181
1833
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
3.5e-01
3.1e-01
8.2e-01
2.4e+00
1.0e+00
4.2e-01
2.8e-01
cases:19.55%
controls:14.67%
cases:16.54%
controls:12.64%
cases:5.76%
controls:2.61%
cases:2.01%
controls:0.18%
cases:5.54%
controls:2.11%
cases:19.74%
controls:13.96%
cases:35.20%
controls:29.01%
78
578
321
3361
66
498
333
3441
23
103
376
3836
8
7
391
3932
22
83
375
3852
76
535
309
3297
126
1021
232
2499
Other obesity
E66.8 [45533036]
1.7e+00
2.3e+00
—
—
—
1.6e+00
8.3e-01
cases:2.01%
controls:0.36%
cases:2.01%
controls:0.20%
—
—
—
—
—
—
cases:1.30%
controls:0.26%
cases:1.68%
controls:0.74%
8
14
391
3925
8
8
391
3931
—
—
—
5
10
380
3822
6
26
352
3494
MCH [Entitic mass]
28539-5 [3035941]
1.2e-01
1.9e-01
6.8e-01
2.6e+00
7.2e-01
2.3e-01
1.0e-01
cases:28.57%
controls:26.12%
cases:25.56%
controls:22.04%
cases:8.52%
controls:4.52%
cases:3.01%
controls:0.23%
cases:8.06%
controls:4.09%
cases:27.53%
controls:23.20%
cases:46.37%
controls:43.81%
114
1029
285
2910
102
868
297
3071
34
178
365
3761
12
9
387
3930
32
161
365
3774
106
889
279
2943
166
1542
192
1978
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.2e-01
1.9e-01
6.8e-01
2.6e+00
7.1e-01
2.2e-01
1.0e-01
cases:28.57%
controls:26.17%
cases:25.56%
controls:22.11%
cases:8.52%
controls:4.52%
cases:3.01%
controls:0.23%
cases:8.06%
controls:4.12%
cases:27.53%
controls:23.30%
cases:46.37%
controls:43.84%
114
1031
285
2908
102
871
297
3068
34
178
365
3761
12
9
387
3930
32
162
365
3773
106
893
279
2939
166
1543
192
1977
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.2e-01
1.9e-01
6.8e-01
2.6e+00
7.1e-01
2.4e-01
1.0e-01
cases:28.57%
controls:26.17%
cases:25.56%
controls:22.11%
cases:8.52%
controls:4.52%
cases:3.01%
controls:0.23%
cases:8.06%
controls:4.12%
cases:27.79%
controls:23.28%
cases:46.37%
controls:43.89%
114
1031
285
2908
102
871
297
3068
34
178
365
3761
12
9
387
3930
32
162
365
3773
107
892
278
2940
166
1545
192
1975
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.2e-01
1.9e-01
6.8e-01
2.6e+00
7.1e-01
2.4e-01
1.0e-01
cases:28.57%
controls:26.17%
cases:25.56%
controls:22.11%
cases:8.52%
controls:4.52%
cases:3.01%
controls:0.23%
cases:8.06%
controls:4.12%
cases:27.79%
controls:23.28%
cases:46.37%
controls:43.86%
114
1031
285
2908
102
871
297
3068
34
178
365
3761
12
9
387
3930
32
162
365
3773
107
892
278
2940
166
1544
192
1976
Platelets [#/volume] in Blood
26515-7 [3007461]
1.3e-01
1.9e-01
6.8e-01
2.6e+00
7.1e-01
2.1e-01
9.2e-02
cases:28.57%
controls:26.02%
cases:25.56%
controls:22.06%
cases:8.52%
controls:4.52%
cases:3.01%
controls:0.23%
cases:8.06%
controls:4.12%
cases:27.27%
controls:23.30%
cases:46.09%
controls:43.81%
114
1025
285
2914
102
869
297
3070
34
178
365
3761
12
9
387
3930
32
162
365
3773
105
893
280
2939
165
1542
193
1978
Case Management Agency
251B00000X [38004193]
-2.6e-02
1.9e-01
5.1e-01
3.5e+00
3.8e-01
2.4e-01
1.1e-01
cases:50.38%
controls:51.03%
cases:47.62%
controls:42.83%
cases:24.56%
controls:16.40%
cases:21.55%
controls:0.84%
cases:22.92%
controls:16.87%
cases:52.21%
controls:46.16%
cases:68.99%
controls:66.53%
201
2010
198
1929
190
1687
209
2252
98
646
301
3293
86
33
313
3906
91
664
306
3271
201
1769
184
2063
247
2342
111
1178
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.2e-01
1.9e-01
6.7e-01
2.6e+00
7.1e-01
2.3e-01
1.0e-01
cases:28.57%
controls:26.20%
cases:25.56%
controls:22.16%
cases:8.52%
controls:4.57%
cases:3.01%
controls:0.23%
cases:8.06%
controls:4.12%
cases:27.79%
controls:23.33%
cases:46.37%
controls:43.86%
114
1032
285
2907
102
873
297
3066
34
180
365
3759
12
9
387
3930
32
162
365
3773
107
894
278
2938
166
1544
192
1976
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.3e-01
1.9e-01
6.8e-01
2.6e+00
7.0e-01
2.4e-01
1.0e-01
cases:28.82%
controls:26.17%
cases:25.56%
controls:22.19%
cases:8.52%
controls:4.52%
cases:3.01%
controls:0.23%
cases:8.06%
controls:4.17%
cases:27.79%
controls:23.25%
cases:46.37%
controls:43.81%
115
1031
284
2908
102
874
297
3065
34
178
365
3761
12
9
387
3930
32
164
365
3771
107
891
278
2941
166
1542
192
1978
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.1e-01
2.5e-01
7.4e-01
2.6e+00
8.7e-01
5.0e-01
2.3e-01
cases:19.05%
controls:15.99%
cases:16.79%
controls:13.53%
cases:5.76%
controls:2.84%
cases:2.01%
controls:0.15%
cases:5.79%
controls:2.52%
cases:20.78%
controls:13.67%
cases:33.52%
controls:28.61%
76
630
323
3309
67
533
332
3406
23
112
376
3827
8
6
391
3933
23
99
374
3836
80
524
305
3308
120
1007
238
2513
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.5e-01
2.3e-01
7.3e-01
2.8e+00
9.0e-01
2.6e-01
1.8e-01
cases:23.56%
controls:20.97%
cases:20.05%
controls:16.58%
cases:6.27%
controls:3.12%
cases:2.01%
controls:0.13%
cases:6.05%
controls:2.54%
cases:21.30%
controls:17.33%
cases:40.22%
controls:35.99%
94
826
305
3113
80
653
319
3286
25
123
374
3816
8
5
391
3934
24
100
373
3835
82
664
303
3168
144
1267
214
2253
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.7e-01
2.1e-01
7.3e-01
2.8e+00
8.6e-01
2.8e-01
2.0e-01
cases:24.06%
controls:21.15%
cases:19.80%
controls:16.65%
cases:6.27%
controls:3.12%
cases:2.01%
controls:0.13%
cases:6.05%
controls:2.64%
cases:22.08%
controls:17.61%
cases:41.06%
controls:36.34%
96
833
303
3106
79
656
320
3283
25
123
374
3816
8
5
391
3934
24
104
373
3831
85
675
300
3157
147
1279
211
2241
Pathology report gross observation
24419-4 [3002256]
5.6e-01
1.2e+00
—
1.0e+50
1.0e+50
2.4e+00
1.1e+00
cases:2.26%
controls:1.29%
cases:2.01%
controls:0.58%
—
—
cases:1.75%
controls:0.00%
cases:1.26%
controls:0.00%
cases:5.71%
controls:0.52%
cases:4.75%
controls:1.59%
9
51
390
3888
8
23
391
3916
—
7
0
392
3939
5
0
392
3935
22
20
363
3812
17
56
341
3464
Supplier / Service Provider
OMOP5117446 [33004]
-1.2e+00
-1.6e+00
—
—
—
3.1e+00
3.2e+00
cases:10.03%
controls:27.77%
cases:2.01%
controls:9.42%
—
—
—
—
—
—
cases:5.97%
controls:0.29%
cases:16.48%
controls:0.77%
40
1094
359
2845
8
371
391
3568
—
—
—
23
11
362
3821
59
27
299
3493
Tissue Pathology biopsy report
66121-5 [40768804]
2.5e-01
6.6e-01
—
1.0e+50
2.3e+00
1.1e+00
5.3e-01
cases:6.77%
controls:5.36%
cases:4.76%
controls:2.51%
—
—
cases:2.51%
controls:0.00%
cases:2.27%
controls:0.23%
cases:7.01%
controls:2.35%
cases:10.61%
controls:6.53%
27
211
372
3728
19
99
380
3840
—
10
0
389
3939
9
9
388
3926
27
90
358
3742
38
230
320
3290
INR in Blood by Coagulation assay
34714-6 [3032080]
2.2e-01
7.2e-01
1.3e+00
—
1.3e+00
6.3e-01
4.1e-01
cases:7.02%
controls:5.69%
cases:7.02%
controls:3.53%
cases:3.76%
controls:1.04%
—
—
cases:3.53%
controls:0.94%
cases:6.75%
controls:3.73%
cases:14.80%
controls:10.31%
28
224
371
3715
28
139
371
3800
15
41
384
3898
—
14
37
383
3898
26
143
359
3689
53
363
305
3157
Orthopedic Surgery
20 [38004465]
4.3e-01
4.6e-01
1.1e+00
—
1.7e+00
7.9e-01
8.2e-01
cases:16.54%
controls:11.40%
cases:7.52%
controls:4.87%
cases:2.26%
controls:0.79%
—
—
cases:3.53%
controls:0.64%
cases:9.87%
controls:4.75%
cases:25.98%
controls:13.35%
66
449
333
3490
30
192
369
3747
9
31
390
3908
—
14
25
383
3910
38
182
347
3650
93
470
265
3050
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
2.1e-01
1.6e-01
5.6e-01
2.4e+00
7.8e-01
1.9e-01
1.6e-01
cases:27.07%
controls:23.15%
cases:21.80%
controls:19.24%
cases:6.77%
controls:3.99%
cases:2.26%
controls:0.20%
cases:7.05%
controls:3.35%
cases:24.16%
controls:20.90%
cases:44.13%
controls:40.17%
108
912
291
3027
87
758
312
3181
27
157
372
3782
9
8
390
3931
28
132
369
3803
93
801
292
3031
158
1414
200
2106
Localized swelling, mass and lump, unspecified
R22.9 [45577788]
5.7e-01
3.2e+00
—
—
—
—
6.9e-01
cases:1.25%
controls:0.71%
cases:3.51%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.96%
controls:0.99%
5
28
394
3911
14
6
385
3933
—
—
—
—
7
35
351
3485
cefalexin; oral
J01DB01 [21602870]
2.3e-01
4.7e-01
5.0e-01
—
1.8e+00
1.1e+00
1.9e-01
cases:30.08%
controls:25.41%
cases:13.53%
controls:8.89%
cases:1.50%
controls:0.91%
—
—
cases:4.28%
controls:0.71%
cases:18.44%
controls:7.28%
cases:28.49%
controls:24.72%
120
1001
279
2938
54
350
345
3589
6
36
393
3903
—
17
28
380
3907
71
279
314
3553
102
870
256
2650
Excision of other lesion extending through all layers of skin in head or neck
QAE10 [2001309784]
—
2.0e+00
—
—
—
2.8e+00
—
—
—
cases:1.25%
controls:0.18%
—
—
—
—
—
—
cases:2.08%
controls:0.13%
—
—
—
5
7
394
3932
—
—
—
8
5
377
3827
—
Scheduled procedure
ZXD10 [2001311387]
3.6e-01
7.3e-01
—
1.0e+50
—
2.0e+00
8.0e-01
cases:7.27%
controls:5.20%
cases:3.01%
controls:1.47%
—
—
cases:2.01%
controls:0.00%
—
—
cases:6.75%
controls:0.99%
cases:7.26%
controls:3.41%
29
205
370
3734
12
58
387
3881
—
8
0
391
3939
—
26
38
359
3794
26
120
332
3400
General anaesthesia
WX402 [2001310806]
7.2e-01
—
—
—
—
1.8e+00
9.4e-01
cases:1.50%
controls:0.74%
—
—
—
—
—
—
—
—
cases:2.86%
controls:0.50%
cases:6.42%
controls:2.61%
6
29
393
3910
—
—
—
—
11
19
374
3813
23
92
335
3428
Day surgery
ZXD20 [2001311388]
6.9e-01
—
—
—
—
2.6e+00
—
cases:2.01%
controls:1.02%
—
—
—
—
—
—
—
—
cases:2.86%
controls:0.21%
—
—
8
40
391
3899
—
—
—
—
11
8
374
3824
—
Neoplasm of uncertain or unknown behaviour: Skin
D48.5 [45586113]
—
2.6e+00
—
—
—
—
1.2e+00
—
—
cases:1.75%
controls:0.13%
—
—
—
—
—
—
—
—
cases:1.96%
controls:0.63%
—
7
5
392
3934
—
—
—
—
7
22
351
3498
Psychiatric/psychological examination
SPAT1243 [2001700344]
-1.0e+50
—
—
—
—
—
2.5e+00
cases:0.00%
controls:0.33%
—
—
—
—
—
—
—
—
—
—
cases:1.68%
controls:0.14%
0
13
399
3926
—
—
—
—
—
6
5
352
3515
Blepharitis
H01.0 [45533180]
2.5e+00
—
—
—
—
—
—
cases:1.75%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
7
6
392
3933
—
—
—
—
—
—
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-1.4e-03
9.0e-02
2.5e-01
2.4e+00
2.1e-01
9.5e-02
-1.2e-01
cases:19.30%
controls:19.32%
cases:16.29%
controls:15.11%
cases:4.01%
controls:3.15%
cases:2.01%
controls:0.18%
cases:3.53%
controls:2.87%
cases:17.14%
controls:15.84%
cases:30.73%
controls:33.32%
77
761
322
3178
65
595
334
3344
16
124
383
3815
8
7
391
3932
14
113
383
3822
66
607
319
3225
110
1173
248
2347
Excision of other lesion extending through all layers of skin of trunk
QBE10 [2001309853]
—
—
—
1.0e+50
—
2.4e+00
—
—
—
—
—
—
—
cases:2.01%
controls:0.00%
—
—
cases:2.86%
controls:0.26%
—
—
—
—
—
8
0
391
3939
—
11
10
374
3822
—
allopurinol; oral, parenteral
M04AA01 [21604131]
8.8e-01
1.1e+00
—
—
—
1.2e+00
1.2e+00
cases:4.01%
controls:1.70%
cases:3.01%
controls:0.99%
—
—
—
—
—
—
cases:3.64%
controls:1.17%
cases:6.15%
controls:2.02%
16
67
383
3872
12
39
387
3900
—
—
—
14
45
371
3787
22
71
336
3449
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
290 [2001600222]
6.5e-01
-1.0e+50
—
—
—
2.3e+00
5.0e-01
cases:1.50%
controls:0.79%
cases:0.00%
controls:0.43%
—
—
—
—
—
—
cases:1.56%
controls:0.16%
cases:2.51%
controls:1.53%
6
31
393
3908
0
17
399
3922
—
—
—
6
6
379
3826
9
54
349
3466
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
2.6e-01
5.1e-01
2.3e+00
—
—
7.1e-01
4.9e-02
cases:5.26%
controls:4.11%
cases:3.26%
controls:1.98%
cases:1.75%
controls:0.18%
—
—
—
—
cases:4.68%
controls:2.35%
cases:8.38%
controls:8.01%
21
162
378
3777
13
78
386
3861
7
7
392
3932
—
—
18
90
367
3742
30
282
328
3238
Physiotherapy
R4110 [2001310233]
1.2e-01
2.1e-01
—
—
—
1.5e+00
8.0e-01
cases:4.01%
controls:3.58%
cases:1.50%
controls:1.22%
—
—
—
—
—
—
cases:4.94%
controls:1.15%
cases:6.42%
controls:2.98%
16
141
383
3798
6
48
393
3891
—
—
—
19
44
366
3788
23
105
335
3415
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
1.9e-01
3.9e-01
2.6e-01
—
1.2e+00
5.5e-01
5.1e-01
cases:30.58%
controls:26.76%
cases:20.55%
controls:14.88%
cases:3.51%
controls:2.72%
—
—
cases:7.56%
controls:2.49%
cases:23.38%
controls:14.93%
cases:45.81%
controls:33.78%
122
1054
277
2885
82
586
317
3353
14
107
385
3832
—
30
98
367
3837
90
572
295
3260
164
1189
194
2331
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6.8e-02
3.7e-01
1.1e+00
—
1.1e+00
2.8e-01
3.1e-01
cases:13.28%
controls:12.52%
cases:11.03%
controls:7.90%
cases:3.51%
controls:1.24%
—
—
cases:3.78%
controls:1.25%
cases:11.43%
controls:8.90%
cases:26.26%
controls:20.65%
53
493
346
3446
44
311
355
3628
14
49
385
3890
—
15
49
382
3886
44
341
341
3491
94
727
264
2793
Immunohistochemistry procedure
117617002 [4035726]
—
9.6e-01
—
—
—
2.2e+00
1.3e+00
—
—
cases:1.25%
controls:0.48%
—
—
—
—
—
—
cases:1.56%
controls:0.18%
cases:2.51%
controls:0.71%
—
5
19
394
3920
—
—
—
6
7
379
3825
9
25
349
3495
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
—
—
—
—
—
2.2e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:1.56%
controls:0.18%
cases:1.96%
controls:0.63%
—
—
—
—
—
6
7
379
3825
7
22
351
3498
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
—
—
—
—
—
2.2e+00
6.8e-01
—
—
—
—
—
—
—
—
—
—
cases:1.56%
controls:0.18%
cases:1.40%
controls:0.71%
—
—
—
—
—
6
7
379
3825
5
25
353
3495
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
-6.6e-02
7.5e-01
1.0e+00
—
1.4e+00
3.5e-01
3.6e-01
cases:6.02%
controls:6.40%
cases:7.52%
controls:3.71%
cases:1.75%
controls:0.63%
—
—
cases:2.52%
controls:0.64%
cases:5.45%
controls:3.89%
cases:15.64%
controls:11.48%
24
252
375
3687
30
146
369
3793
7
25
392
3914
—
10
25
387
3910
21
149
364
3683
56
404
302
3116
pregabalin; oral
N02BF02 [955152]
3.1e-01
1.1e+00
—
—
—
1.1e+00
1.0e+00
cases:4.01%
controls:2.97%
cases:3.01%
controls:1.07%
—
—
—
—
—
—
cases:3.64%
controls:1.25%
cases:7.54%
controls:2.93%
16
117
383
3822
12
42
387
3897
—
—
—
14
48
371
3784
27
103
331
3417
Intravenous general anesthesia
WX404 [2001310807]
5.1e-01
1.2e-01
—
—
—
2.0e+00
6.6e-01
cases:3.76%
controls:2.28%
cases:1.25%
controls:1.12%
—
—
—
—
—
—
cases:3.12%
controls:0.42%
cases:1.96%
controls:1.02%
15
90
384
3849
5
44
394
3895
—
—
—
12
16
373
3816
7
36
351
3484
Multidisciplinary treatment meeting
WZC20 [2001310890]
-1.0e+50
—
—
—
—
—
2.0e+00
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:1.68%
controls:0.23%
0
8
399
3931
—
—
—
—
—
6
8
352
3512
General Practice
1 [38004446]
2.3e-01
4.3e-02
1.6e+00
—
2.0e+00
5.1e-01
2.8e-01
cases:12.78%
controls:10.46%
cases:4.76%
controls:4.57%
cases:2.01%
controls:0.43%
—
—
cases:2.52%
controls:0.36%
cases:6.75%
controls:4.15%
cases:14.80%
controls:11.56%
51
412
348
3527
19
180
380
3759
8
17
391
3922
—
10
14
387
3921
26
159
359
3673
53
407
305
3113
Rubber band ligature of haemorrhoids or prolapse of mucosa
JHB30 [2001305142]
2.0e+00
—
—
—
—
-1.0e+50
1.6e+00
cases:2.51%
controls:0.36%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:1.40%
controls:0.28%
10
14
389
3925
—
—
—
—
0
5
385
3827
5
10
353
3510
Microorganisms panel - Urine sediment
58435-9 [40761536]
3.7e-01
1.9e+00
—
—
—
6.6e-01
7.1e-01
cases:1.75%
controls:1.22%
cases:2.76%
controls:0.41%
—
—
—
—
—
—
cases:1.30%
controls:0.68%
cases:3.07%
controls:1.53%
7
48
392
3891
11
16
388
3923
—
—
—
5
26
380
3806
11
54
347
3466
Emergency Medicine
93 [38004510]
2.2e-01
5.1e-01
1.9e+00
1.0e+50
—
4.7e-01
3.0e-01
cases:10.78%
controls:8.81%
cases:8.02%
controls:4.98%
cases:2.76%
controls:0.43%
cases:1.50%
controls:0.00%
—
—
cases:7.79%
controls:5.04%
cases:21.23%
controls:16.70%
43
347
356
3592
32
196
367
3743
11
17
388
3922
6
0
393
3939
—
30
193
355
3639
76
588
282
2932
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
—
1.9e+00
—
—
—
—
6.3e-01
—
—
cases:1.75%
controls:0.28%
—
—
—
—
—
—
—
—
cases:2.79%
controls:1.51%
—
7
11
392
3928
—
—
—
—
10
53
348
3467
Occupational therapy
R4120 [2001310234]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.96%
controls:0.31%
—
—
—
—
—
—
7
11
351
3509
More than one and less than three hours
ZXE10 [2001311401]
5.8e-01
6.3e-01
—
1.0e+50
—
1.8e+00
5.9e-01
cases:7.52%
controls:4.37%
cases:2.51%
controls:1.35%
—
—
cases:1.50%
controls:0.00%
—
—
cases:5.19%
controls:0.89%
cases:6.15%
controls:3.49%
30
172
369
3767
10
53
389
3886
—
6
0
393
3939
—
20
34
365
3798
22
123
336
3397
Suture or treatment of traumatic wound
SPAT1149 [2001700250]
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
cases:2.34%
controls:0.39%
—
—
—
—
—
—
—
9
15
376
3817
—
Bacteria identified in Isolate by Culture
43409-2 [3042936]
1.7e-01
1.2e+00
—
—
—
1.8e+00
-3.7e-01
cases:1.50%
controls:1.27%
cases:1.75%
controls:0.53%
—
—
—
—
—
—
cases:1.82%
controls:0.31%
cases:1.68%
controls:2.41%
6
50
393
3889
7
21
392
3918
—
—
—
7
12
378
3820
6
85
352
3435
Medical Oncology
90 [38004507]
-4.3e-01
-1.2e-01
1.3e+00
1.0e+50
7.7e-01
9.7e-01
7.9e-01
cases:2.01%
controls:3.05%
cases:1.75%
controls:1.98%
cases:1.75%
controls:0.48%
cases:1.25%
controls:0.00%
cases:1.26%
controls:0.58%
cases:4.68%
controls:1.83%
cases:6.70%
controls:3.15%
8
120
391
3819
7
78
392
3861
7
19
392
3920
5
0
394
3939
5
23
392
3912
18
70
367
3762
24
111
334
3409
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
—
6.5e-01
—
—
—
1.7e+00
4.9e-01
—
—
cases:1.25%
controls:0.66%
—
—
—
—
—
—
cases:2.34%
controls:0.42%
cases:3.07%
controls:1.90%
—
5
26
394
3913
—
—
—
9
16
376
3816
11
67
347
3453
Left side
ZXA05 [2001311347]
3.6e-01
3.8e-01
—
—
—
1.7e+00
7.5e-01
cases:4.26%
controls:3.02%
cases:1.25%
controls:0.86%
—
—
—
—
—
—
cases:4.16%
controls:0.76%
cases:5.59%
controls:2.73%
17
119
382
3820
5
34
394
3905
—
—
—
16
29
369
3803
20
96
338
3424
Office Visit
OMOP4822458 [581477]
-2.1e-01
3.7e-01
1.5e+00
—
1.7e+00
7.7e-01
3.7e-01
cases:6.77%
controls:8.20%
cases:3.76%
controls:2.61%
cases:1.25%
controls:0.28%
—
—
cases:2.27%
controls:0.41%
cases:4.42%
controls:2.09%
cases:9.22%
controls:6.56%
27
323
372
3616
15
103
384
3836
5
11
394
3928
—
9
16
388
3919
17
80
368
3752
33
231
325
3289
Lump/swelling localized
S04 [2002000969]
—
1.7e+00
—
—
—
1.6e+00
3.5e-01
—
—
cases:2.26%
controls:0.41%
—
—
—
—
—
—
cases:1.30%
controls:0.26%
cases:1.96%
controls:1.39%
—
9
16
390
3923
—
—
—
5
10
380
3822
7
49
351
3471
CBC panel - Blood by Automated count
58410-2 [40761511]
1.6e-01
1.0e-01
8.1e-01
—
9.0e-01
3.1e-01
2.0e-01
cases:24.31%
controls:21.53%
cases:17.29%
controls:15.87%
cases:5.76%
controls:2.64%
—
—
cases:5.54%
controls:2.34%
cases:20.26%
controls:15.71%
cases:39.66%
controls:34.91%
97
848
302
3091
69
625
330
3314
23
104
376
3835
—
22
92
375
3843
78
602
307
3230
142
1229
216
2291
Pharmacy visit
OMOP4822462 [581458]
1.0e-01
1.7e-01
1.2e-01
1.7e+00
2.2e-01
2.8e-01
2.1e-01
cases:88.47%
controls:87.36%
cases:80.20%
controls:77.38%
cases:44.36%
controls:41.41%
cases:10.03%
controls:2.01%
cases:45.84%
controls:40.41%
cases:82.86%
controls:78.58%
cases:91.90%
controls:90.20%
353
3441
46
498
320
3048
79
891
177
1631
222
2308
40
79
359
3860
182
1590
215
2345
319
3011
66
821
329
3175
29
345
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
1.2e-01
1.5e+00
—
—
—
1.7e+00
5.0e-01
cases:1.25%
controls:1.12%
cases:2.26%
controls:0.53%
—
—
—
—
—
—
cases:2.08%
controls:0.39%
cases:2.23%
controls:1.36%
5
44
394
3895
9
21
390
3918
—
—
—
8
15
377
3817
8
48
350
3472
Hand and fingers X-ray examination
ND2AA [2001307607]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.51%
controls:0.48%
—
—
—
—
—
—
9
17
349
3503
General medical examination
Z00.0 [45585791]
6.4e-01
—
—
—
—
1.6e+00
7.5e-01
cases:4.01%
controls:2.16%
—
—
—
—
—
—
—
—
cases:2.08%
controls:0.42%
cases:4.47%
controls:2.16%
16
85
383
3854
—
—
—
—
8
16
377
3816
16
76
342
3444
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
6.7e-02
3.6e-01
9.5e-01
—
1.6e+00
4.5e-01
2.4e-01
cases:13.03%
controls:12.29%
cases:9.77%
controls:7.01%
cases:2.01%
controls:0.79%
—
—
cases:2.52%
controls:0.51%
cases:10.39%
controls:6.86%
cases:23.46%
controls:19.38%
52
484
347
3455
39
276
360
3663
8
31
391
3908
—
10
20
387
3915
40
263
345
3569
84
682
274
2838
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
9.0e-02
3.5e-01
1.6e+00
—
1.3e+00
6.3e-01
3.0e-01
cases:8.27%
controls:7.62%
cases:5.51%
controls:3.94%
cases:2.26%
controls:0.46%
—
—
cases:1.26%
controls:0.36%
cases:6.75%
controls:3.73%
cases:16.76%
controls:12.95%
33
300
366
3639
22
155
377
3784
9
18
390
3921
—
5
14
392
3921
26
143
359
3689
60
456
298
3064
Pain in joint
M25.5 [45586941]
8.9e-01
4.8e-01
—
—
—
8.7e-01
7.2e-01
cases:7.02%
controls:3.00%
cases:1.75%
controls:1.09%
—
—
—
—
—
—
cases:2.34%
controls:0.99%
cases:9.22%
controls:4.72%
28
118
371
3821
7
43
392
3896
—
—
—
9
38
376
3794
33
166
325
3354
Right side
ZXA00 [2001311346]
2.8e-01
2.9e-01
—
1.0e+50
—
1.6e+00
3.7e-01
cases:4.01%
controls:3.05%
cases:1.25%
controls:0.94%
—
—
cases:3.01%
controls:0.00%
—
—
cases:3.12%
controls:0.65%
cases:3.91%
controls:2.73%
16
120
383
3819
5
37
394
3902
—
12
0
387
3939
—
12
25
373
3807
14
96
344
3424
Intravenous sedation or analgesia without general anesthesia
WX006 [2001310762]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.79%
controls:0.60%
—
—
—
—
—
—
10
21
348
3499
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.51%
controls:0.54%
—
—
—
—
—
—
9
19
349
3501
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
3.9e-01
—
—
—
—
—
1.4e+00
cases:2.01%
controls:1.37%
—
—
—
—
—
—
—
—
—
—
cases:3.07%
controls:0.77%
8
54
391
3885
—
—
—
—
—
11
27
347
3493
FEV1/FVC
19926-5 [3011505]
3.9e-01
—
—
—
—
—
1.4e+00
cases:2.01%
controls:1.37%
—
—
—
—
—
—
—
—
—
—
cases:3.07%
controls:0.77%
8
54
391
3885
—
—
—
—
—
11
27
347
3493
FEV1
20150-9 [3024653]
3.9e-01
—
—
—
—
—
1.4e+00
cases:2.01%
controls:1.37%
—
—
—
—
—
—
—
—
—
—
cases:3.07%
controls:0.77%
8
54
391
3885
—
—
—
—
—
11
27
347
3493
Pneumonia, unspecified
J18.9 [45601123]
-2.3e-01
1.3e+00
—
—
—
—
-1.5e-03
cases:2.01%
controls:2.51%
cases:3.26%
controls:0.89%
—
—
—
—
—
—
—
—
cases:3.63%
controls:3.64%
8
99
391
3840
13
35
386
3904
—
—
—
—
13
128
345
3392
Thorax X-ray examination
GD1AA [2001303617]
-4.2e-02
2.0e-01
—
—
—
1.3e+00
4.0e-01
cases:5.51%
controls:5.74%
cases:3.26%
controls:2.69%
—
—
—
—
—
—
cases:5.71%
controls:1.67%
cases:8.66%
controls:5.99%
22
226
377
3713
13
106
386
3833
—
—
—
22
64
363
3768
31
211
327
3309
ABO and Rh group [Type] in Blood
882-1 [3003694]
-5.5e-02
6.5e-01
—
—
—
1.2e+00
4.0e-01
cases:3.01%
controls:3.17%
cases:2.26%
controls:1.19%
—
—
—
—
—
—
cases:3.38%
controls:0.99%
cases:6.70%
controls:4.60%
12
125
387
3814
9
47
390
3892
—
—
—
13
38
372
3794
24
162
334
3358
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
6.1e-01
6.1e-01
1.5e+00
—
—
2.6e-01
6.3e-01
cases:10.03%
controls:5.69%
cases:4.76%
controls:2.64%
cases:1.50%
controls:0.36%
—
—
—
—
cases:3.12%
controls:2.43%
cases:11.17%
controls:6.31%
40
224
359
3715
19
104
380
3835
6
14
393
3925
—
—
12
93
373
3739
40
222
318
3298
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
2.1e-01
1.2e+00
—
—
—
9.5e-01
3.9e-01
cases:3.26%
controls:2.67%
cases:3.26%
controls:0.99%
—
—
—
—
—
—
cases:2.60%
controls:1.02%
cases:5.03%
controls:3.47%
13
105
386
3834
13
39
386
3900
—
—
—
10
39
375
3793
18
122
340
3398
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
3.1e-01
1.2e+00
—
—
—
8.2e-01
2.2e-01
cases:2.76%
controls:2.03%
cases:4.01%
controls:1.24%
—
—
—
—
—
—
cases:3.38%
controls:1.51%
cases:6.70%
controls:5.45%
11
80
388
3859
16
49
383
3890
—
—
—
13
58
372
3774
24
192
334
3328
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
3.5e-01
2.5e-01
—
—
—
1.2e+00
5.8e-01
cases:5.26%
controls:3.76%
cases:2.51%
controls:1.95%
—
—
—
—
—
—
cases:4.42%
controls:1.44%
cases:8.94%
controls:5.23%
21
148
378
3791
10
77
389
3862
—
—
—
17
55
368
3777
32
184
326
3336
Hand/finger symptom/complaint
L12 [2002000636]
-4.6e-02
1.1e+00
—
—
—
—
1.1e+00
cases:1.50%
controls:1.57%
cases:1.25%
controls:0.41%
—
—
—
—
—
—
—
—
cases:5.59%
controls:1.88%
6
62
393
3877
5
16
394
3923
—
—
—
—
20
66
338
3454
ibuprofen
R02AX02 [1588667]
1.5e-01
3.0e-01
8.2e-01
—
6.9e-01
6.3e-01
4.2e-01
cases:35.34%
controls:32.09%
cases:18.30%
controls:14.27%
cases:4.01%
controls:1.80%
—
—
cases:4.79%
controls:2.47%
cases:23.38%
controls:14.01%
cases:42.46%
controls:32.59%
141
1264
258
2675
73
562
326
3377
16
71
383
3868
—
19
97
378
3838
90
537
295
3295
152
1147
206
2373
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
1.5e-01
3.0e-01
8.2e-01
—
6.9e-01
6.3e-01
4.2e-01
cases:35.34%
controls:32.09%
cases:18.30%
controls:14.27%
cases:4.01%
controls:1.80%
—
—
cases:4.79%
controls:2.47%
cases:23.38%
controls:14.01%
cases:42.46%
controls:32.59%
141
1264
258
2675
73
562
326
3377
16
71
383
3868
—
19
97
378
3838
90
537
295
3295
152
1147
206
2373
12 lead EKG panel
34534-8 [3044889]
1.8e-01
3.7e-01
9.1e-01
—
1.2e+00
6.1e-01
4.4e-01
cases:12.28%
controls:10.48%
cases:8.52%
controls:6.07%
cases:1.75%
controls:0.71%
—
—
cases:2.27%
controls:0.71%
cases:10.39%
controls:5.92%
cases:25.42%
controls:18.04%
49
413
350
3526
34
239
365
3700
7
28
392
3911
—
9
28
388
3907
40
227
345
3605
91
635
267
2885
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
2.8e-01
4.6e-01
—
—
1.8e+00
1.0e+00
6.1e-01
cases:4.26%
controls:3.25%
cases:2.76%
controls:1.75%
—
—
—
—
cases:1.51%
controls:0.25%
cases:3.90%
controls:1.41%
cases:7.54%
controls:4.26%
17
128
382
3811
11
69
388
3870
—
—
6
10
391
3925
15
54
370
3778
27
150
331
3370
Headache
R51.80 [2000503603]
1.0e+00
-1.0e+50
—
—
—
7.4e-01
6.0e-01
cases:3.51%
controls:1.27%
cases:0.00%
controls:0.51%
—
—
—
—
—
—
cases:1.30%
controls:0.63%
cases:3.35%
controls:1.88%
14
50
385
3889
0
20
399
3919
—
—
—
5
24
380
3808
12
66
346
3454
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
3.0e-01
1.0e+00
—
—
1.8e+00
9.5e-01
4.0e-01
cases:4.26%
controls:3.20%
cases:3.76%
controls:1.37%
—
—
—
—
cases:1.26%
controls:0.20%
cases:3.38%
controls:1.33%
cases:6.98%
controls:4.77%
17
126
382
3813
15
54
384
3885
—
—
5
8
392
3927
13
51
372
3781
25
168
333
3352
Counselling related to known health issue
SPAT1310 [2001700411]
-7.6e-03
1.0e+00
—
—
—
—
4.1e-01
cases:4.51%
controls:4.54%
cases:3.76%
controls:1.37%
—
—
—
—
—
—
—
—
cases:6.98%
controls:4.74%
18
179
381
3760
15
54
384
3885
—
—
—
—
25
167
333
3353
Other and unspecified abdominal pain
R10.4 [45568113]
4.4e-01
1.0e+00
—
—
—
2.4e-01
4.5e-01
cases:6.02%
controls:3.96%
cases:3.76%
controls:1.40%
—
—
—
—
—
—
cases:1.82%
controls:1.44%
cases:8.38%
controls:5.51%
24
156
375
3783
15
55
384
3884
—
—
—
7
55
378
3777
30
194
328
3326
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
2.4e-01
1.0e+00
—
—
—
-3.0e-01
3.2e-01
cases:5.51%
controls:4.39%
cases:6.02%
controls:2.28%
—
—
—
—
—
—
cases:2.08%
controls:2.79%
cases:10.06%
controls:7.50%
22
173
377
3766
24
90
375
3849
—
—
—
8
107
377
3725
36
264
322
3256
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1.6e-01
1.0e+00
—
—
-1.0e+50
-1.6e-01
6.9e-03
cases:3.76%
controls:3.22%
cases:3.76%
controls:1.42%
—
—
—
—
cases:0.00%
controls:0.18%
cases:1.30%
controls:1.51%
cases:7.26%
controls:7.22%
15
127
384
3812
15
56
384
3883
—
—
0
7
397
3928
5
58
380
3774
26
254
332
3266
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
3.2e-01
9.7e-01
—
—
1.7e+00
7.8e-01
4.6e-01
cases:5.26%
controls:3.88%
cases:4.51%
controls:1.75%
—
—
—
—
cases:1.26%
controls:0.23%
cases:3.90%
controls:1.83%
cases:9.22%
controls:6.05%
21
153
378
3786
18
69
381
3870
—
—
5
9
392
3926
15
70
370
3762
33
213
325
3307
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
2.8e-01
9.6e-01
—
—
—
6.8e-01
4.1e-01
cases:5.76%
controls:4.42%
cases:5.26%
controls:2.08%
—
—
—
—
—
—
cases:4.16%
controls:2.14%
cases:9.78%
controls:6.73%
23
174
376
3765
21
82
378
3857
—
—
—
16
82
369
3750
35
237
323
3283
Inpatient Visit
IP [9201]
2.1e-01
2.9e-01
1.9e+00
1.0e+50
—
9.5e-01
5.3e-01
cases:7.27%
controls:5.99%
cases:2.76%
controls:2.08%
cases:1.50%
controls:0.23%
cases:6.77%
controls:0.00%
—
—
cases:5.71%
controls:2.30%
cases:12.57%
controls:7.81%
29
236
370
3703
11
82
388
3857
6
9
393
3930
27
0
372
3939
—
22
88
363
3744
45
275
313
3245
Rheumatology
66 [38004491]
6.2e-01
2.0e-01
—
—
—
5.0e-01
9.3e-01
cases:5.01%
controls:2.77%
cases:2.26%
controls:1.85%
—
—
—
—
—
—
cases:2.60%
controls:1.59%
cases:7.26%
controls:2.98%
20
109
379
3830
9
73
390
3866
—
—
—
10
61
375
3771
26
105
332
3415
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
1.1e-01
8.8e-01
9.9e-01
—
9.2e-01
3.7e-01
2.2e-01
cases:7.52%
controls:6.78%
cases:8.27%
controls:3.60%
cases:1.75%
controls:0.66%
—
—
cases:1.76%
controls:0.71%
cases:5.71%
controls:4.02%
cases:13.69%
controls:11.34%
30
267
369
3672
33
142
366
3797
7
26
392
3913
—
7
28
390
3907
22
154
363
3678
49
399
309
3121
ethylmorphine; oral
R05DA01 [21603397]
-7.5e-02
—
—
—
—
4.8e-01
8.7e-01
cases:2.01%
controls:2.16%
—
—
—
—
—
—
—
—
cases:1.30%
controls:0.81%
cases:5.59%
controls:2.41%
8
85
391
3854
—
—
—
—
5
31
380
3801
20
85
338
3435
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
1.5e-01
8.5e-01
9.9e-01
—
6.1e-01
3.0e-01
1.7e-01
cases:7.52%
controls:6.55%
cases:8.02%
controls:3.60%
cases:1.75%
controls:0.66%
—
—
cases:1.26%
controls:0.69%
cases:5.19%
controls:3.91%
cases:12.85%
controls:11.05%
30
258
369
3681
32
142
367
3797
7
26
392
3913
—
5
27
392
3908
20
150
365
3682
46
389
312
3131
Pain localized to other parts of lower abdomen
R10.3 [45534426]
4.1e-01
9.5e-01
—
—
—
7.0e-01
8.4e-01
cases:3.76%
controls:2.54%
cases:2.26%
controls:0.89%
—
—
—
—
—
—
cases:1.56%
controls:0.78%
cases:6.98%
controls:3.15%
15
100
384
3839
9
35
390
3904
—
—
—
6
30
379
3802
25
111
333
3409
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
2.1e-01
8.2e-01
1.1e+00
—
9.5e-01
3.3e-01
1.9e-01
cases:7.77%
controls:6.40%
cases:8.02%
controls:3.71%
cases:1.75%
controls:0.58%
—
—
cases:1.76%
controls:0.69%
cases:5.45%
controls:3.97%
cases:13.13%
controls:11.08%
31
252
368
3687
32
146
367
3793
7
23
392
3916
—
7
27
390
3908
21
152
364
3680
47
390
311
3130
Basophils/Leukocytes in Blood
30180-4 [3022096]
2.1e-01
8.2e-01
1.1e+00
—
9.5e-01
3.3e-01
1.9e-01
cases:7.77%
controls:6.37%
cases:8.02%
controls:3.71%
cases:1.75%
controls:0.58%
—
—
cases:1.76%
controls:0.69%
cases:5.45%
controls:3.99%
cases:13.13%
controls:11.11%
31
251
368
3688
32
146
367
3793
7
23
392
3916
—
7
27
390
3908
21
153
364
3679
47
391
311
3129
Obstetrics / Gynecology
16 [38004461]
1.7e-01
5.7e-01
1.3e+00
1.0e+50
7.5e-01
8.2e-01
4.4e-01
cases:16.04%
controls:13.89%
cases:9.02%
controls:5.33%
cases:2.51%
controls:0.69%
cases:3.26%
controls:0.00%
cases:1.76%
controls:0.84%
cases:9.35%
controls:4.36%
cases:19.55%
controls:13.58%
64
547
335
3392
36
210
363
3729
10
27
389
3912
13
0
386
3939
7
33
390
3902
36
167
349
3665
70
478
288
3042
Differential panel, method unspecified - Blood
69738-3 [42870588]
3.5e-01
8.2e-01
1.4e+00
—
—
3.1e-01
2.8e-01
cases:5.26%
controls:3.78%
cases:5.51%
controls:2.51%
cases:1.25%
controls:0.30%
—
—
—
—
cases:3.64%
controls:2.69%
cases:8.66%
controls:6.70%
21
149
378
3790
22
99
377
3840
5
12
394
3927
—
—
14
103
371
3729
31
236
327
3284
Monocytes/Leukocytes in Blood
26485-3 [3019069]
1.7e-01
8.1e-01
1.1e+00
—
9.5e-01
3.3e-01
2.1e-01
cases:7.52%
controls:6.40%
cases:8.02%
controls:3.73%
cases:1.75%
controls:0.61%
—
—
cases:1.76%
controls:0.69%
cases:5.45%
controls:3.99%
cases:13.41%
controls:11.16%
30
252
369
3687
32
147
367
3792
7
24
392
3915
—
7
27
390
3908
21
153
364
3679
48
393
310
3127
Cardiology
6 [38004451]
3.8e-01
5.5e-01
9.5e-01
—
1.1e+00
8.1e-01
4.8e-01
cases:10.28%
controls:7.24%
cases:5.51%
controls:3.25%
cases:1.50%
controls:0.58%
—
—
cases:1.51%
controls:0.53%
cases:6.75%
controls:3.13%
cases:13.13%
controls:8.52%
41
285
358
3654
22
128
377
3811
6
23
393
3916
—
6
21
391
3914
26
120
359
3712
47
300
311
3220
enoxaparin; parenteral
B01AB05 [21600976]
6.7e-01
1.6e-01
—
—
—
9.3e-01
7.9e-01
cases:6.27%
controls:3.30%
cases:1.25%
controls:1.07%
—
—
—
—
—
—
cases:2.60%
controls:1.04%
cases:8.10%
controls:3.84%
25
130
374
3809
5
42
394
3897
—
—
—
10
40
375
3792
29
135
329
3385
Rotator cuff syndrome
M75.1 [45596678]
2.6e-01
5.0e-01
—
—
-1.0e+50
5.6e-01
7.5e-01
cases:3.01%
controls:2.34%
cases:1.25%
controls:0.76%
—
—
—
—
cases:0.00%
controls:0.18%
cases:1.82%
controls:1.04%
cases:7.54%
controls:3.72%
12
92
387
3847
5
30
394
3909
—
—
0
7
397
3928
7
40
378
3792
27
131
331
3389
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
6.4e-02
7.4e-01
7.2e-01
—
9.8e-01
1.8e-01
1.3e-01
cases:7.52%
controls:7.08%
cases:7.77%
controls:3.86%
cases:1.50%
controls:0.74%
—
—
cases:2.02%
controls:0.76%
cases:5.19%
controls:4.36%
cases:13.69%
controls:12.24%
30
279
369
3660
31
152
368
3787
6
29
393
3910
—
8
30
389
3905
20
167
365
3665
49
431
309
3089
Normoblasts [#/volume] in Blood
715-3 [3021589]
3.8e-01
7.1e-01
1.2e+00
—
9.2e-01
6.3e-01
4.1e-01
cases:7.02%
controls:4.93%
cases:8.02%
controls:4.11%
cases:2.76%
controls:0.81%
—
—
cases:2.52%
controls:1.02%
cases:8.05%
controls:4.44%
cases:14.53%
controls:10.17%
28
194
371
3745
32
162
367
3777
11
32
388
3907
—
10
40
387
3895
31
170
354
3662
52
358
306
3162
Monocytes [#/volume] in Blood
26484-6 [3001604]
1.1e-01
7.1e-01
7.9e-01
—
1.0e+00
1.6e-01
1.1e-01
cases:7.27%
controls:6.55%
cases:7.52%
controls:3.86%
cases:1.50%
controls:0.69%
—
—
cases:2.02%
controls:0.74%
cases:4.94%
controls:4.23%
cases:13.13%
controls:11.90%
29
258
370
3681
30
152
369
3787
6
27
393
3912
—
8
29
389
3906
19
162
366
3670
47
419
311
3101
Basophils [#/volume] in Blood
26444-0 [3006315]
9.9e-02
7.1e-01
7.9e-01
—
1.0e+00
1.6e-01
1.1e-01
cases:7.27%
controls:6.63%
cases:7.52%
controls:3.86%
cases:1.50%
controls:0.69%
—
—
cases:2.02%
controls:0.74%
cases:4.94%
controls:4.25%
cases:13.13%
controls:11.96%
29
261
370
3678
30
152
369
3787
6
27
393
3912
—
8
29
389
3906
19
163
366
3669
47
421
311
3099
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
5.5e-01
8.4e-01
—
—
1.5e+00
5.7e-01
6.6e-01
cases:10.28%
controls:6.17%
cases:5.01%
controls:2.23%
—
—
—
—
cases:1.76%
controls:0.41%
cases:4.16%
controls:2.40%
cases:11.17%
controls:6.11%
41
243
358
3696
20
88
379
3851
—
—
7
16
390
3919
16
92
369
3740
40
215
318
3305
Intramuscular and subcutaneous injection
SPAT1256 [2001700357]
-2.0e-01
-5.4e-01
—
—
—
2.7e-01
6.6e-01
cases:5.01%
controls:6.07%
cases:1.50%
controls:2.56%
—
—
—
—
—
—
cases:3.64%
controls:2.79%
cases:13.69%
controls:7.59%
20
239
379
3700
6
101
393
3838
—
—
—
14
107
371
3725
49
267
309
3253
Pulmonary Disease
29 [38004472]
1.9e-01
4.3e-01
7.3e-01
—
1.3e+00
1.9e-01
6.1e-01
cases:8.02%
controls:6.73%
cases:5.26%
controls:3.48%
cases:1.25%
controls:0.61%
—
—
cases:1.51%
controls:0.43%
cases:4.16%
controls:3.47%
cases:12.57%
controls:7.22%
32
265
367
3674
21
137
378
3802
5
24
394
3915
—
6
17
391
3918
16
133
369
3699
45
254
313
3266
esomeprazole; oral, parenteral
A02BC05 [21600100]
5.4e-01
2.1e-01
3.5e-01
—
—
4.2e-01
6.1e-01
cases:11.78%
controls:7.21%
cases:4.76%
controls:3.91%
cases:1.25%
controls:0.89%
—
—
—
—
cases:5.45%
controls:3.65%
cases:13.41%
controls:7.76%
47
284
352
3655
19
154
380
3785
5
35
394
3904
—
—
21
140
364
3692
48
273
310
3247
Internal Medicine
11 [38004456]
3.4e-01
3.5e-01
9.7e-01
—
8.5e-01
6.0e-01
3.9e-01
cases:22.81%
controls:17.44%
cases:9.52%
controls:6.88%
cases:2.26%
controls:0.86%
—
—
cases:2.52%
controls:1.09%
cases:12.73%
controls:7.39%
cases:25.42%
controls:18.78%
91
687
308
3252
38
271
361
3668
9
34
390
3905
—
10
43
387
3892
49
283
336
3549
91
661
267
2859
etoricoxib; oral
M01AH05 [21603996]
3.3e-01
2.9e-01
8.8e-01
—
—
3.1e-01
5.9e-01
cases:14.79%
controls:11.07%
cases:6.52%
controls:4.98%
cases:2.01%
controls:0.84%
—
—
—
—
cases:6.75%
controls:5.04%
cases:24.30%
controls:15.14%
59
436
340
3503
26
196
373
3743
8
33
391
3906
—
—
26
193
359
3639
87
533
271
2987
tizanidine; oral
M03BX02 [21604116]
2.2e-01
5.1e-01
—
—
—
6.2e-01
5.5e-01
cases:14.79%
controls:12.21%
cases:6.27%
controls:3.86%
—
—
—
—
—
—
cases:7.01%
controls:3.89%
cases:18.72%
controls:11.68%
59
481
340
3458
25
152
374
3787
—
—
—
27
149
358
3683
67
411
291
3109
Dental X-ray, bite-wing X-ray on one side of the mouth
EB1SA [2001301918]
-1.4e-02
2.7e-01
—
—
-1.0e+50
-1.0e-01
5.4e-01
cases:8.52%
controls:8.63%
cases:3.76%
controls:2.89%
—
—
—
—
cases:0.00%
controls:0.23%
cases:2.34%
controls:2.58%
cases:17.60%
controls:11.08%
34
340
365
3599
15
114
384
3825
—
—
0
9
397
3926
9
99
376
3733
63
390
295
3130
Otolaryngology
4 [38004449]
3.5e-01
5.8e-01
—
1.0e+50
—
6.6e-01
5.3e-01
cases:13.53%
controls:9.95%
cases:6.77%
controls:3.91%
—
—
cases:3.26%
controls:0.00%
—
—
cases:5.97%
controls:3.18%
cases:16.76%
controls:10.63%
54
392
345
3547
27
154
372
3785
—
13
0
386
3939
—
23
122
362
3710
60
374
298
3146
Emergency Room Visit
ER [9203]
2.9e-01
2.5e-01
1.0e+00
—
6.4e-01
4.2e-01
4.9e-01
cases:34.09%
controls:27.93%
cases:13.28%
controls:10.66%
cases:2.76%
controls:0.99%
—
—
cases:2.02%
controls:1.07%
cases:14.03%
controls:9.66%
cases:37.71%
controls:27.07%
136
1100
263
2839
53
420
346
3519
11
39
388
3900
—
8
42
389
3893
54
370
331
3462
135
953
223
2567
dexbrompheniramine, combinations
R06AB56 [21603469]
—
—
—
—
—
-1.0e+50
3.4e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.39%
cases:1.40%
controls:0.99%
—
—
—
—
—
0
15
385
3817
5
35
353
3485
nicotinic acid, combinations
C10AD52 [21601887]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
—
Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
10634-4 [3023659]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
—
glipizide; oral
A10BB07 [21600756]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
0
7
399
3932
—
—
—
—
—
0
5
358
3515
Eye sensation abnormal
F13 [2002000404]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
Other bipolar affective disorders
F31.8 [45586237]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
—
Benign lipomatous neoplasm
D17 [45537894]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
0
6
358
3514
Sensorineural hearing loss, bilateral
H90.3 [45576850]
2.7e-01
2.9e-01
—
—
—
1.2e-01
7.4e-01
cases:2.51%
controls:1.93%
cases:1.25%
controls:0.94%
—
—
—
—
—
—
cases:1.30%
controls:1.15%
cases:5.87%
controls:2.90%
10
76
389
3863
5
37
394
3902
—
—
—
5
44
380
3788
21
102
337
3418
hydroxychloroquine; oral
P01BA02 [21604889]
6.2e-01
—
—
—
—
5.4e-01
6.5e-01
cases:2.01%
controls:1.09%
—
—
—
—
—
—
—
—
cases:1.56%
controls:0.91%
cases:2.79%
controls:1.48%
8
43
391
3896
—
—
—
—
6
35
379
3797
10
52
348
3468
Psychiatric monitoring contact
IGY02 [2001304322]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
0
8
358
3512
Emotionally unstable personality disorder
F60.3 [45566852]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
0
6
399
3933
—
—
—
—
—
0
5
358
3515
Lyme disease
A69.2 [45595594]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
0
6
399
3933
—
—
—
0
5
385
3827
—
Ingrowing nail
L60.0 [45548199]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.36%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
0
14
399
3925
—
—
—
—
0
6
385
3826
—
Block dissection of axillary lymph nodes
PJD52 [2001309638]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
0
18
399
3921
—
—
—
—
—
0
9
358
3511
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
3.2e-01
—
—
—
—
6.9e-01
-3.4e-02
cases:1.25%
controls:0.91%
—
—
—
—
—
—
—
—
cases:1.30%
controls:0.65%
cases:1.68%
controls:1.73%
5
36
394
3903
—
—
—
—
5
25
380
3807
6
61
352
3459
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
7.7e-01
9.4e-01
—
—
—
8.3e-01
3.2e-01
cases:4.76%
controls:2.26%
cases:2.51%
controls:0.99%
—
—
—
—
—
—
cases:2.60%
controls:1.15%
cases:4.75%
controls:3.49%
19
89
380
3850
10
39
389
3900
—
—
—
10
44
375
3788
17
123
341
3397
propranolol and thiazides
C07BA05 [21601704]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:0.00%
controls:0.14%
—
0
5
399
3934
—
—
—
0
5
385
3827
0
5
358
3515
hydrocortisone
A07EA02 [21600654]
-1.2e-01
-8.7e-02
—
—
—
6.6e-02
5.5e-01
cases:6.27%
controls:7.01%
cases:2.01%
controls:2.18%
—
—
—
—
—
—
cases:2.34%
controls:2.19%
cases:10.61%
controls:6.39%
25
276
374
3663
8
86
391
3853
—
—
—
9
84
376
3748
38
225
320
3295
Wrist X-ray examination
ND1AA [2001307576]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
—
0
8
385
3824
—
Recurrent dislocation and subluxation of joint
M24.4 [45557843]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
—
pimecrolimus
D11AH02 [21602339]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
Paraesthesia of skin
R20.2 [45568120]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
—
0
8
385
3824
—
leuprorelin; implant, parenteral
L02AE02 [21603825]
—
—
—
—
-1.0e+50
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:0.00%
controls:0.26%
cases:0.00%
controls:0.40%
—
—
—
—
0
5
397
3930
0
10
385
3822
0
14
358
3506
Poisoning by systemic antibiotics
T36 [45756588]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.33%
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
0
13
399
3926
0
6
399
3933
—
—
—
—
—
combinations of different antibiotics
S01AA30 [21603578]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
399
3930
—
—
—
—
—
—
Basocellular carcinoma of the skin on the torso
C44.51 [2000500800]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
10
358
3510
Hystero-salpingography with ultrasound
LC2HE [2001306546]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
—
—
—
—
—
—
0
16
399
3923
—
—
—
—
—
—
hydrocortisone butyrate
D07AB02 [21602106]
-1.1e-01
-8.7e-02
—
—
—
7.8e-02
5.2e-01
cases:6.27%
controls:6.96%
cases:2.01%
controls:2.18%
—
—
—
—
—
—
cases:2.34%
controls:2.17%
cases:10.34%
controls:6.39%
25
274
374
3665
8
86
391
3853
—
—
—
9
83
376
3749
37
225
321
3295
Health check-up performed based on health survey in students of universities, universities of applied sciences etc.
SPAT1366 [2001700467]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
399
3932
—
—
—
—
—
—
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
3.9e-01
3.9e-01
9.6e-01
—
—
1.8e-01
1.4e-01
cases:9.02%
controls:6.30%
cases:5.76%
controls:3.96%
cases:1.25%
controls:0.48%
—
—
—
—
cases:4.68%
controls:3.94%
cases:15.36%
controls:13.61%
36
248
363
3691
23
156
376
3783
5
19
394
3920
—
—
18
151
367
3681
55
479
303
3041
Nonorganic sleep disorders
F51 [45552491]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
399
3932
—
—
—
—
—
—
celecoxib
L01XX33 [21603805]
5.8e-01
—
—
—
-1.0e+50
1.1e+00
4.4e-01
cases:2.51%
controls:1.42%
—
—
—
—
—
—
cases:0.00%
controls:0.15%
cases:1.56%
controls:0.52%
cases:2.79%
controls:1.82%
10
56
389
3883
—
—
—
0
6
397
3929
6
20
379
3812
10
64
348
3456
Paroxysmal atrial fibrillation
I48.0 [45581776]
—
—
—
—
—
—
1.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.96%
controls:0.63%
—
—
—
—
—
—
7
22
351
3498
lithium; oral
N05AN01 [21604556]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
0
9
399
3930
—
—
—
0
8
385
3824
—
Skin injury other
S19 [2002000984]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
CD3+CD8+ (T8 suppressor) cells/cells in Blood
8101-8 [3007449]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
0
6
358
3514
Migraine
G43 [45566873]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.51%
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
0
20
399
3919
0
8
399
3931
—
—
—
—
—
Paracervical blockade
WX234 [2001310789]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
399
3933
—
—
—
—
—
—
sulfadiazine and trimethoprim
J01EE02 [21602962]
1.5e-01
8.1e-01
—
—
—
—
2.3e-01
cases:3.51%
controls:3.05%
cases:1.75%
controls:0.79%
—
—
—
—
—
—
—
—
cases:2.51%
controls:2.02%
14
120
385
3819
7
31
392
3908
—
—
—
—
9
71
349
3449
zinc preparations; ointment
C05AX04 [21601632]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
—
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
2.8e-01
-2.5e-01
—
—
—
-2.2e-02
5.3e-01
cases:4.01%
controls:3.05%
cases:1.25%
controls:1.60%
—
—
—
—
—
—
cases:1.56%
controls:1.59%
cases:6.70%
controls:4.06%
16
120
383
3819
5
63
394
3876
—
—
—
6
61
379
3771
24
143
334
3377
Counselling and guidance related to occupational health
SPAT1311 [2001700412]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.53%
—
—
—
—
—
—
—
—
—
—
—
—
0
21
399
3918
—
—
—
—
—
—
Sciatica
M54.3 [45586994]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.33%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
0
13
399
3926
—
—
—
—
0
7
385
3825
—
Primary arthrosis of other joints
M19.0 [45601353]
5.9e-01
—
—
—
—
—
9.8e-01
cases:1.50%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
cases:2.23%
controls:0.85%
6
33
393
3906
—
—
—
—
—
8
30
350
3490
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
D48.9 [45532986]
—
—
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:1.30%
controls:0.00%
—
—
—
—
—
—
—
5
0
380
3832
—
Screening for hearing loss
710076008 [46271821]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
399
3933
—
—
—
—
—
—
Vena saphena Magna and / or swarm of nodule and possible local emissions
5611 [2000100813]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
399
3933
—
—
—
—
—
—
oxybutynin; oral, transdermal
G04BD04 [21602637]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
0
6
399
3933
—
—
—
—
—
General and Unspecified, Medical examin/health eval partial
A31 [2002000165]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
0
8
399
3931
—
—
—
—
—
0
5
358
3515
Plain photography of ocular fundus
CK2S4 [2001301455]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
0
7
385
3825
—
ispaghula (psylla seeds); oral
A06AC01 [21600555]
-5.2e-01
—
-1.0e+50
—
—
1.4e-01
6.3e-01
cases:1.50%
controls:2.51%
—
—
cases:0.00%
controls:0.25%
—
—
—
—
cases:1.56%
controls:1.36%
cases:6.15%
controls:3.38%
6
99
393
3840
—
0
10
399
3929
—
—
6
52
379
3780
22
119
336
3401
Breast Pathology biopsy report
66110-8 [40768793]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.25%
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
0
10
399
3929
0
6
399
3933
—
—
—
—
0
9
358
3511
mometasone, combinations
R01AD59 [947911]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
levothyroxine sodium; oral, parenteral
H03AA01 [21602754]
-2.1e-02
-1.0e-01
-2.9e-01
—
1.9e-01
-4.9e-02
-1.0e-01
cases:8.02%
controls:8.17%
cases:7.52%
controls:8.28%
cases:2.01%
controls:2.67%
—
—
cases:3.27%
controls:2.72%
cases:8.31%
controls:8.69%
cases:9.50%
controls:10.43%
32
322
367
3617
30
326
369
3613
8
105
391
3834
—
13
107
384
3828
32
333
353
3499
34
367
324
3153
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.30%
controls:0.13%
—
—
—
—
—
—
—
5
5
380
3827
—
Erythrocytes [Presence] in Urine
33051-4 [3045424]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
—
C reactive protein [Mass/volume] in Body fluid
16503-5 [3035320]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
cases:0.00%
controls:0.23%
—
—
—
—
—
0
6
385
3826
0
8
358
3512
Elbow X-ray examination without contrast
NC1AA [2001307421]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
399
3932
—
—
—
—
—
—
almotriptan; oral
N02CC05 [21604380]
—
—
—
—
—
—
1.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.68%
controls:0.60%
—
—
—
—
—
—
6
21
352
3499
Adenocarcinoma, NOS, of prostate gland
8140/3-C61.9 [44499685]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
0
7
399
3932
—
—
—
—
—
metoprolol and felodipine
C07FB02 [21601742]
-1.0e+50
-1.0e+50
-1.0e+50
—
—
-1.0e+50
—
cases:0.00%
controls:0.58%
cases:0.00%
controls:0.48%
cases:0.00%
controls:0.20%
—
—
—
—
cases:0.00%
controls:0.50%
—
—
0
23
399
3916
0
19
399
3920
0
8
399
3931
—
—
0
19
385
3813
—
Measurement of blood pressure with Doppler ultrasound device
SPAT1099 [2001700200]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
—
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
—
0
14
399
3925
—
—
—
—
—
Wedge excision of mammary gland
HAB40 [2001303928]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.28%
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
0
11
399
3928
0
6
399
3933
—
—
—
—
0
7
358
3513
Contusion of thorax
S20.2 [45597402]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
—
—
0
12
399
3927
—
—
—
—
—
—
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
-1.0e+50
-1.0e+50
—
—
—
—
6.4e-01
cases:0.00%
controls:0.84%
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.40%
controls:0.74%
0
33
399
3906
0
6
399
3933
—
—
—
—
5
26
353
3494
dexketoprofen; oral, parenteral
M01AE17 [21603983]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
0
5
399
3934
—
—
—
—
—
0
6
358
3514
Outlining of treatment with patient or their family members
SPAT1276 [2001700377]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
0
8
399
3931
—
—
—
—
—
0
11
358
3509
Subarachnoid haemorrhage from anterior communicating artery
I60.2 [45548024]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
—
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
1.5e-01
4.4e-01
—
—
—
9.3e-01
4.3e-01
cases:3.01%
controls:2.59%
cases:1.75%
controls:1.14%
—
—
—
—
—
—
cases:2.86%
controls:1.15%
cases:5.59%
controls:3.72%
12
102
387
3837
7
45
392
3894
—
—
—
11
44
374
3788
20
131
338
3389
olanzapine; oral, parenteral
N05AH03 [21604543]
—
—
-1.0e+50
—
—
—
3.7e-01
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
cases:1.40%
controls:0.97%
—
—
0
6
399
3933
—
—
—
5
34
353
3486
Leiomyoma of uterus, unspecified
D25.9 [45542693]
6.2e-01
—
—
—
—
—
—
cases:1.50%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
6
32
393
3907
—
—
—
—
—
—
Sleep disorder, unspecified
G47.9 [45595948]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
0
5
399
3934
—
—
—
—
0
8
358
3512
Curettage of body of uterus
LCA10 [2001306552]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
0
6
358
3514
Puncture of pleura with ultrasound guidance
GA4YT [2001303531]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
0
7
358
3513
Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18500-9 [3018006]
-2.4e-01
2.9e-01
—
—
-1.0e+50
—
2.6e-01
cases:2.26%
controls:2.84%
cases:1.25%
controls:0.94%
—
—
—
—
cases:0.00%
controls:0.13%
—
—
cases:3.91%
controls:3.04%
9
112
390
3827
5
37
394
3902
—
—
0
5
397
3930
—
14
107
344
3413
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
3.4e-01
-5.3e-02
-1.0e+50
—
-1.0e+50
1.3e-02
1.8e-01
cases:5.51%
controls:3.99%
cases:2.51%
controls:2.64%
cases:0.00%
controls:0.30%
—
—
cases:0.00%
controls:0.25%
cases:3.12%
controls:3.08%
cases:10.61%
controls:9.03%
22
157
377
3782
10
104
389
3835
0
12
399
3927
—
0
10
397
3925
12
118
373
3714
38
318
320
3202
ramipril and diuretics
C09BA05 [21601807]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.28%
cases:0.00%
controls:0.15%
—
—
—
—
—
—
cases:0.00%
controls:0.18%
cases:0.00%
controls:0.20%
0
11
399
3928
0
6
399
3933
—
—
—
0
7
385
3825
0
7
358
3513
chloramphenicol; ointment
D06AX02 [21602063]
—
—
—
—
—
—
1.9e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.68%
controls:1.39%
—
—
—
—
—
—
6
49
352
3471
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
1.7e-02
2.5e-01
—
—
—
-2.4e-01
3.7e-03
cases:19.05%
controls:18.79%
cases:14.29%
controls:11.45%
—
—
—
—
—
—
cases:10.13%
controls:12.50%
cases:33.52%
controls:33.44%
76
740
323
3199
57
451
342
3488
—
—
—
39
479
346
3353
120
1177
238
2343
Open wound of other parts of lower leg
S81.8 [45564809]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
399
3933
—
—
—
—
—
—
mometasone; inhalant
R03BA07 [21603290]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
0
5
358
3515
Implantation of electrocardiograph with loop recorder
FPK00 [2001303218]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
0
7
358
3513
Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11054-4 [3002109]
—
-1.0e+50
—
—
—
—
-2.1e-01
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
—
—
cases:2.23%
controls:2.76%
—
0
22
399
3917
—
—
—
—
8
97
350
3423
Acute inflammatory disease of uterus
N71.0 [45596880]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.13%
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
0
5
399
3934
0
5
399
3934
—
—
—
—
0
9
358
3511
Cephalometry with X-ray
EB1MA [2001301916]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
399
3933
—
—
—
—
—
—
Thrombin time
3243-3 [3036489]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
0
7
385
3825
—
Throat symptom/complaint
R21 [2002000891]
-1.4e-01
—
—
—
—
—
1.1e-01
cases:2.26%
controls:2.59%
—
—
—
—
—
—
—
—
—
—
cases:3.63%
controls:3.27%
9
102
390
3837
—
—
—
—
—
13
115
345
3405
itraconazole; oral, parenteral
J02AC02 [21603081]
7.4e-01
—
-1.0e+50
—
—
—
—
cases:3.26%
controls:1.57%
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
13
62
386
3877
—
0
5
399
3934
—
—
—
—
clomipramine; oral, parenteral
N06AA04 [21604691]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
399
3933
—
—
—
—
—
—
Electroconvulsive therapy
AA400 [2001300694]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
—
Diabetes, non-insulin-treated
215 [2001600211]
-1.0e-01
—
—
—
—
-1.0e+50
8.3e-02
cases:2.26%
controls:2.49%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
cases:3.63%
controls:3.35%
9
98
390
3841
—
—
—
—
0
23
385
3809
13
118
345
3402
Split tooth for reasons other than trauma
K03.82 [2000502700]
6.9e-01
—
—
—
—
6.6e-01
5.1e-01
cases:1.25%
controls:0.63%
—
—
—
—
—
—
—
—
cases:1.30%
controls:0.68%
cases:6.42%
controls:3.95%
5
25
394
3914
—
—
—
—
5
26
380
3806
23
139
335
3381
Open wound of finger(s) without damage to nail
S61.0 [45578756]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
0
12
385
3820
—
terbutaline; inhalant
R03AC03 [21603257]
7.1e-01
9.7e-01
-1.0e+50
—
—
—
8.0e-01
cases:4.01%
controls:2.01%
cases:2.51%
controls:0.96%
cases:0.00%
controls:0.28%
—
—
—
—
—
—
cases:4.19%
controls:1.93%
16
79
383
3860
10
38
389
3901
0
11
399
3928
—
—
—
15
68
343
3452
Removal of fixed intravenous catheter
TPH90 [2001309607]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
399
3933
—
—
—
—
—
—
methylprednisolone, combinations
H02BX01 [21602747]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.40%
—
0
6
399
3933
—
—
—
—
0
14
358
3506
Protein [Mass] in Urine collected for unspecified duration
32551-4 [3017817]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
0
5
358
3515
Periodontal treatment, very brief
SDA01 [2001310326]
3.6e-01
—
—
—
—
3.0e-01
6.3e-01
cases:4.26%
controls:3.02%
—
—
—
—
—
—
—
—
cases:1.30%
controls:0.97%
cases:7.54%
controls:4.15%
17
119
382
3820
—
—
—
—
5
37
380
3795
27
146
331
3374
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
3.8e-01
—
—
—
—
—
5.5e-01
cases:1.25%
controls:0.86%
—
—
—
—
—
—
—
—
—
—
cases:3.35%
controls:1.96%
5
34
394
3905
—
—
—
—
—
12
69
346
3451
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: current
SMOKING-1-1-1 [2002330115]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.53%
—
—
—
—
—
—
—
—
—
—
—
0
21
399
3918
—
—
—
—
—
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
4.0e-01
4.3e-01
1.0e+00
—
—
2.1e-01
1.7e-01
cases:8.77%
controls:6.07%
cases:5.76%
controls:3.83%
cases:1.25%
controls:0.46%
—
—
—
—
cases:4.68%
controls:3.81%
cases:15.08%
controls:13.07%
35
239
364
3700
23
151
376
3788
5
18
394
3921
—
—
18
146
367
3686
54
460
304
3060
Vertigo/dizziness
N17 [2002000728]
—
—
—
—
—
-1.0e+50
9.0e-02
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.37%
cases:1.68%
controls:1.53%
—
—
—
—
—
0
14
385
3818
6
54
352
3466
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
9.1e-01
—
—
—
—
-1.0e+50
—
cases:1.50%
controls:0.61%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
6
24
393
3915
—
—
—
—
0
9
385
3823
—
pH of Venous blood
2746-6 [3012544]
—
—
—
—
—
—
-1.4e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.68%
controls:1.93%
—
—
—
—
—
—
6
68
352
3452
Laparoscopic unilateral salpingo-oophorectomy
LAF01 [2001306442]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
399
3933
—
—
—
—
—
—
Photoangiography of eye
XCD20 [2001301379]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
399
3933
—
—
—
—
—
—
filgrastim; parenteral
L03AA02 [21603851]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.15%
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
0
6
399
3933
0
6
399
3933
—
—
—
—
0
8
358
3512
Lipid panel - Serum or Plasma
100898-6 [1761868]
4.6e-02
5.1e-01
—
—
-1.0e+50
1.8e-01
1.4e-01
cases:5.01%
controls:4.80%
cases:5.01%
controls:3.07%
—
—
—
—
cases:0.00%
controls:0.28%
cases:3.90%
controls:3.26%
cases:13.41%
controls:11.82%
20
189
379
3750
20
121
379
3818
—
—
0
11
397
3924
15
125
370
3707
48
416
310
3104
Hip joint ultrasound examination
NF1AE [2001307895]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.25%
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
0
10
399
3929
0
5
399
3934
—
—
—
—
0
7
358
3513
Spirometry
127783003 [4133840]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
0
5
399
3934
—
—
—
—
0
7
358
3513
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
399
3928
—
—
—
—
—
—
formoterol and budesonide
R03AK07 [21603281]
-7.2e-02
—
—
—
—
—
-2.7e-01
cases:1.25%
controls:1.35%
—
—
—
—
—
—
—
—
—
—
cases:1.40%
controls:1.82%
5
53
394
3886
—
—
—
—
—
5
64
353
3456
Gastroscopy
UJD02 [2001304787]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
—
—
—
—
—
—
1.4e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.40%
controls:1.22%
—
—
—
—
—
—
5
43
353
3477
tiaprofenic acid; oral, rectal
M01AE11 [21603977]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
0
7
399
3932
—
—
—
—
0
5
385
3827
—
Radiculopathy
M54.1 [45577287]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
Changing form of teeth in prepation for prosthodontic work
SPA00 [2001310458]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
0
7
399
3932
—
—
—
—
—
propranolol; oral, parenteral
C07AA05 [21601670]
3.1e-02
—
—
—
—
3.7e-02
2.8e-01
cases:3.01%
controls:2.92%
—
—
—
—
—
—
—
—
cases:1.30%
controls:1.25%
cases:4.47%
controls:3.41%
12
115
387
3824
—
—
—
—
5
48
380
3784
16
120
342
3400
Hip symptom/complaint
L13 [2002000637]
6.5e-01
—
-1.0e+50
—
—
5.7e-01
1.9e-01
cases:2.51%
controls:1.32%
—
—
cases:0.00%
controls:0.13%
—
—
—
—
cases:1.56%
controls:0.89%
cases:2.79%
controls:2.33%
10
52
389
3887
—
0
5
399
3934
—
—
6
34
379
3798
10
82
348
3438
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
—
—
—
—
—
—
3.9e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.96%
controls:1.34%
—
—
—
—
—
—
7
47
351
3473
Extensive high resolution CT examination of lungs
GD1ED [2001303637]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.41%
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
0
16
399
3923
0
5
399
3934
—
—
—
—
—
Cutaneous abscess, furuncle and carbuncle of trunk
L02.2 [45586751]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
399
3930
—
—
—
—
—
—
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
—
—
—
—
—
1.0e+00
5.2e-01
—
—
—
—
—
—
—
—
—
—
cases:1.30%
controls:0.47%
cases:2.23%
controls:1.34%
—
—
—
—
—
5
18
380
3814
8
47
350
3473
Apolipoprotein B [Mass/volume] in Serum or Plasma
1884-6 [3014791]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
Pelvic, hip and femur MRI examination with high intensity magnet
NE1BG [2001307800]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
399
3933
—
—
—
—
—
—
Pure hypercholesterolaemia
E78.01 [2000501514]
-3.7e-01
—
—
—
-1.0e+50
5.9e-01
-2.1e-01
cases:1.25%
controls:1.80%
—
—
—
—
—
—
cases:0.00%
controls:0.15%
cases:1.82%
controls:1.02%
cases:2.79%
controls:3.44%
5
71
394
3868
—
—
—
0
6
397
3929
7
39
378
3793
10
121
348
3399
Overweight
T83 [2002001126]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
0
6
358
3514
Erythrocytes [#/volume] in Pleural fluid
26456-4 [3028308]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
0
7
358
3513
Health maint/preventive medicine
A98 [2002000231]
1.9e-02
1.6e-02
2.3e-01
—
3.3e-01
1.5e-01
2.4e-02
cases:27.32%
controls:26.94%
cases:18.80%
controls:18.56%
cases:3.76%
controls:3.00%
—
—
cases:3.78%
controls:2.74%
cases:22.60%
controls:20.04%
cases:44.69%
controls:44.09%
109
1061
290
2878
75
731
324
3208
15
118
384
3821
—
15
108
382
3827
87
768
298
3064
160
1552
198
1968
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
FN2BA [2001303090]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
0
5
399
3934
—
—
—
0
5
385
3827
—
Other ulcerative colitis
K51.8 [45586720]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
0
5
399
3934
—
—
—
—
—
0
7
358
3513
Striking against or struck by other object(s)
W22 [45756260]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
0
6
399
3933
—
—
—
—
—
lidocaine; ointment
D04AB01 [21602020]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
—
—
—
—
—
—
—
—
—
—
0
13
399
3926
—
—
—
—
—
—
dexamethasone; oral, parenteral
H02AB02 [21602730]
-4.4e-01
—
—
—
-1.0e+50
9.2e-01
4.8e-01
cases:1.25%
controls:1.93%
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:1.30%
controls:0.52%
cases:3.63%
controls:2.27%
5
76
394
3863
—
—
—
0
5
397
3930
5
20
380
3812
13
80
345
3440
Glutamate decarboxylase 65 Ab [Units/volume] in Serum
13926-1 [3020148]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
399
3931
—
—
—
—
—
—
Acute upper respiratory infection, unspecified
J06.9 [45562437]
3.2e-01
2.4e-01
—
—
-1.0e+50
6.1e-01
4.8e-01
cases:7.77%
controls:5.74%
cases:3.26%
controls:2.59%
—
—
—
—
cases:0.00%
controls:0.20%
cases:4.42%
controls:2.45%
cases:15.36%
controls:10.09%
31
226
368
3713
13
102
386
3837
—
—
0
8
397
3927
17
94
368
3738
55
355
303
3165
mometasone
D07AC13 [21602132]
-1.2e-01
—
—
—
-1.0e+50
—
4.2e-01
cases:3.76%
controls:4.21%
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
cases:4.75%
controls:3.18%
15
166
384
3773
—
—
—
0
8
397
3927
—
17
112
341
3408
Oral alveoplasty
ECB20 [2001301973]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
—
Urology
34 [38004474]
2.9e-01
5.4e-01
—
—
—
7.2e-01
4.7e-01
cases:5.51%
controls:4.19%
cases:3.76%
controls:2.23%
—
—
—
—
—
—
cases:4.68%
controls:2.32%
cases:7.82%
controls:5.06%
22
165
377
3774
15
88
384
3851
—
—
—
18
89
367
3743
28
178
330
3342
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
—
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
hydroxyethylpromethazine, combinations
R06AD55 [21603490]
-1.7e-01
—
—
—
—
—
3.7e-01
cases:1.75%
controls:2.08%
—
—
—
—
—
—
—
—
—
—
cases:1.96%
controls:1.36%
7
82
392
3857
—
—
—
—
—
7
48
351
3472
Skin, Other therap proced/minor surg NEC
S59 [2002001023]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
—
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:0.00%
controls:0.37%
—
—
—
—
—
0
5
385
3827
0
13
358
3507
Conduction disorder, unspecified
I45.9 [45601037]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
0
5
399
3934
—
—
—
—
—
Retrognaty, mandibular
K07.13 [2000502762]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
0
9
358
3511
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
26975-3 [3025245]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
—
—
0
14
399
3925
—
—
—
—
—
—
Fungus identified in Specimen by Culture
580-1 [3000494]
—
—
—
—
—
—
1.5e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.23%
controls:1.93%
—
—
—
—
—
—
8
68
350
3452
Ultrasound examination of thorax
GA1AE [2001303415]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
0
5
399
3934
—
—
—
—
—
0
8
358
3512
Guidance concerning hydration
SPAT1172 [2001700273]
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:0.00%
controls:0.13%
—
—
0
7
399
3932
—
—
—
0
5
397
3930
0
5
385
3827
—
gabapentin; oral
N02BF01 [955005]
-3.7e-01
—
—
—
—
—
1.9e-01
cases:1.25%
controls:1.80%
—
—
—
—
—
—
—
—
—
—
cases:3.35%
controls:2.78%
5
71
394
3868
—
—
—
—
—
12
98
346
3422
Other function in accordance with SHToL (Finnish classification of nursing interventions)
SPAT1292 [2001700393]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
—
0
12
399
3927
—
—
—
—
—
Intravenous
ZX120 [2001311495]
—
—
—
—
—
—
4.3e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.40%
controls:0.91%
—
—
—
—
—
—
5
32
353
3488
trichlormethiazide; oral
C03AA06 [21601469]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:0.00%
controls:0.14%
—
0
5
399
3934
—
—
—
0
5
385
3827
0
5
358
3515
dexamethasone and antiinfectives
S01CA01 [21603652]
—
—
—
—
—
—
3.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.51%
controls:1.76%
—
—
—
—
—
—
9
62
349
3458
Normetanephrine [Moles/volume] in Serum or Plasma
25489-6 [3026179]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
0
6
385
3826
—
Type 2 diabetes mellitus
E11 [45571656]
5.8e-04
-2.6e-01
—
—
—
5.5e-02
-4.5e-03
cases:3.76%
controls:3.76%
cases:1.25%
controls:1.62%
—
—
—
—
—
—
cases:1.82%
controls:1.72%
cases:4.47%
controls:4.49%
15
148
384
3791
5
64
394
3875
—
—
—
7
66
378
3766
16
158
342
3362
Syncope and collapse
R55 [45568141]
5.9e-01
-1.0e+50
—
—
—
-1.0e+50
—
cases:1.50%
controls:0.84%
cases:0.00%
controls:0.38%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
6
33
393
3906
0
15
399
3924
—
—
—
0
10
385
3822
—
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
351 [2001600312]
6.5e-01
—
—
—
—
—
3.0e-01
cases:1.25%
controls:0.66%
—
—
—
—
—
—
—
—
—
—
cases:1.96%
controls:1.45%
5
26
394
3913
—
—
—
—
—
7
51
351
3469
Shoulder and humerus MRI examination with high intensity magnet
NB1BG [2001307231]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
0
6
358
3514
Norclozapine [Moles/volume] in Serum or Plasma
14851-0 [3008832]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
399
3933
—
—
—
—
—
—
Sprain and strain of toe(s)
S93.5 [45555651]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
0
6
358
3514
Myeloperoxidase Ab [Units/volume] in Serum
6969-0 [3023150]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
0
6
399
3933
—
—
—
—
—
pravastatin; oral
C10AA03 [21601858]
—
—
-1.0e+50
—
—
1.4e+00
6.0e-01
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
cases:1.30%
controls:0.31%
cases:1.96%
controls:1.08%
—
—
0
7
399
3932
—
—
5
12
380
3820
7
38
351
3482
agomelatine; oral
N06AX22 [21604750]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
0
7
358
3513

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
103
534
2.20
10.34
1.3
1.2
—
—
—
0
0
217
1614
1.67
6.53
2.2
2.1
—
—
—
0
0
234
1817
1.60
5.63
12.2
11.9
1.20
1.21
inr
0.15
186
1497
184
1408
1.52
4.39
3.2
3.2
31.07
31.61
u/l
0.09
175
1343
276
2316
1.50
4.10
4.6
4.7
6.74
6.65
mmol/l
0.26
268
2188
123
886
1.53
3.80
1.8
1.6
0.87
1.22
mg/l
1.60
105
704
223
1815
1.45
3.73
13.0
11.2
0.00
0.00
e9/l
0.12
189
1494
55
326
1.78
3.64
2.4
2.8
65.95
67.00
g/l
0.41
50
310
30
144
2.16
3.62
1.8
1.6
21.50
21.38
s
0.02
24
131
114
820
1.52
3.52
1.4
1.3
21.31
33.05
iu/ml
1.43
38
252
82
550
1.60
3.43
5.1
6.7
105.23
104.13
mmol/l
1.63
82
550
219
1798
1.42
3.39
7.0
6.0
1.22
1.21
mmol/l
0.51
207
1651
155
1205
1.44
3.20
6.5
6.5
—
—
—
0
0
70
461
1.61
3.16
1.9
1.7
—
—
—
0
0
133
1022
1.43
2.88
3.1
2.7
324.96
340.14
umol/l
1.03
125
916
12
38
3.22
2.87
1.3
1.4
—
—
—
0
0
305
2702
1.40
2.79
4.9
4.5
—
2.79
—
0
7
151
1194
1.40
2.77
3.0
3.2
1574.54
1217.31
ng/l
0.34
133
1017
250
2149
1.37
2.72
6.7
6.6
11.53
10.99
umol/l
0.30
236
2047
79
554
1.52
2.72
1.1
1.2
—
—
—
0
0
247
2122
1.36
2.69
4.1
4.0
0.00
0.00
estimate
-0.00
68
462
44
268
1.71
2.68
1.2
1.2
—
—
—
0
0
81
573
1.50
2.67
1.9
2.0
—
—
—
0
0
249
2143
1.36
2.67
4.1
4.0
19.00
0.00
estimate
0.49
71
470
15
61
2.51
2.64
1.3
1.1
4.67
3.78
u/ml
—
6
27
55
358
1.61
2.61
5.4
7.2
1.53
1.37
mmol/l
0.24
55
353
336
3044
1.41
2.57
4.8
4.4
14.89
14.75
pmol/l
0.50
316
2793
219
1863
1.34
2.47
2.8
2.7
—
—
estimate
—
0
0
44
275
1.67
2.46
1.7
2.3
—
—
—
0
0
223
1907
1.34
2.40
6.4
6.2
57.34
57.25
%
0.04
216
1825
264
2315
1.34
2.39
9.4
10.0
4.02
4.04
e9/l
0.08
232
2015
163
1332
1.35
2.38
5.9
6.0
—
—
—
0
0
11
39
2.87
2.36
2.5
2.0
87.03
90.71
%
0.54
11
39
143
1150
1.36
2.30
3.9
3.1
0.33
0.45
e6/l
0.57
114
845
232
2004
1.33
2.30
7.3
6.9
1.21
1.21
mmol/l
0.14
198
1728
221
1896
1.33
2.30
6.6
6.3
0.63
0.69
%
0.80
212
1777
248
2163
1.33
2.29
4.1
4.0
0.00
0.69
estimate
0.50
68
439
169
1397
1.34
2.26
3.7
3.4
2.36
2.36
mmol/l
0.06
157
1271
7
18
3.93
2.26
2.1
4.1
517.86
876.56
u/ml
—
7
18
12
48
2.54
2.20
1.2
1.2
—
—
—
0
0
56
382
1.53
2.20
2.2
2.1
0.11
0.03
estimate
0.28
19
91
49
328
1.55
2.10
3.8
3.6
—
—
—
0
0
80
593
1.42
2.08
1.3
1.4
308.00
507.61
titre
1.21
20
142
117
925
1.36
2.08
3.3
2.6
5.86
5.48
e6/l
0.09
111
853
220
1904
1.30
2.08
6.6
6.3
8.85
8.79
%
0.13
211
1794
64
455
1.47
2.07
6.2
7.7
-0.08
0.92
mmol/l
0.77
55
389
66
474
1.46
2.03
1.3
1.3
—
—
—
0
0
70
509
1.44
2.02
5.3
5.3
1.02
1.04
mmol/l
0.17
64
473
219
1900
1.30
2.01
6.6
6.2
2.87
2.84
%
0.06
210
1786
69
503
1.44
1.97
1.6
2.5
153.76
121.63
ug/g
0.17
51
394
15
71
2.15
1.94
1.0
1.1
—
—
—
0
0
16
78
2.09
1.93
1.1
1.1
—
—
—
0
0
383
3604
1.42
1.91
6.0
5.4
1.85
1.90
mu/l
0.40
363
3334
222
1939
1.29
1.90
6.6
6.2
28.18
27.80
%
0.20
215
1848
234
2059
1.28
1.89
6.7
6.2
0.54
0.57
e9/l
1.15
210
1772
157
1313
1.30
1.87
2.4
2.3
—
—
—
0
0
63
458
1.44
1.83
6.0
7.7
7.41
7.42
ph
0.23
32
266
120
970
1.32
1.83
3.9
3.8
—
0.38
—
0
8
5
12
4.20
1.83
7.0
3.1
37.48
43.42
g/l
—
5
12
150
1252
1.30
1.81
2.4
2.0
175.20
192.86
u/l
0.23
139
1181
234
2068
1.27
1.79
6.7
6.2
0.04
0.04
e9/l
0.11
210
1780
18
95
1.93
1.78
1.2
1.2
—
—
—
0
0
14
67
2.12
1.78
1.6
1.4
—
—
—
0
0
12
54
2.26
1.75
1.3
1.3
—
—
nmol/l
—
0
0
117
951
1.31
1.71
5.1
5.0
—
—
—
0
0
330
3055
1.30
1.69
8.9
8.2
75.09
77.80
u/l
0.91
317
2894
13
62
2.13
1.67
3.5
2.5
2.40
2.48
mmol/l
—
7
42
299
2736
1.28
1.66
4.8
4.1
—
0.17
—
0
6
240
2140
1.26
1.66
6.8
6.4
0.18
0.19
e9/l
0.07
216
1865
7
25
2.83
1.65
1.0
1.1
—
—
—
0
0
175
1505
1.27
1.64
4.5
3.8
23.29
69.83
ng/l
0.66
124
1069
10
42
2.41
1.62
1.3
1.5
27.40
33.60
ng/l
—
10
42
200
1751
1.26
1.60
5.0
4.7
35.80
35.92
g/l
0.12
188
1658
28
176
1.63
1.59
2.3
1.9
—
—
—
0
0
6
20
3.03
1.58
2.2
1.6
127.67
152.35
nmol/l
—
6
20
17
92
1.88
1.58
2.4
2.2
127.73
128.37
g/l
0.04
11
72
236
2108
1.25
1.58
6.7
6.2
1.81
1.92
e9/l
0.78
213
1858
189
1649
1.25
1.55
3.9
3.8
0.00
0.02
estimate
1.15
49
386
31
202
1.57
1.53
2.1
2.1
0.06
0.01
estimate
0.34
18
79
157
1343
1.26
1.52
4.2
3.2
45.33
107.59
e6/l
0.63
129
1038
47
336
1.45
1.51
3.0
2.4
10.33
10.35
g/l
0.01
40
314
402
3847
1.42
1.51
18.8
15.3
20.01
22.40
mg/l
0.95
347
3157
95
765
1.31
1.48
1.4
1.3
7.84
13.26
u/ml
0.59
40
307
175
1522
1.25
1.45
5.1
3.9
58.83
90.75
e6/l
0.63
137
1081
96
777
1.30
1.44
3.5
2.8
532.34
535.16
mosm/kgh2o
0.04
90
688
20
118
1.73
1.43
1.4
1.3
313.08
306.79
ug/g
0.04
12
66
389
3711
1.36
1.41
5.4
5.1
5.92
5.92
mmol/l
0.00
363
3426
108
890
1.28
1.41
1.6
1.4
2.85
2.43
g/l
0.49
67
549
119
993
1.27
1.41
1.4
1.3
1.80
1.58
u/ml
0.08
28
283
9
40
2.27
1.41
1.1
2.5
—
—
—
0
0
47
342
1.42
1.39
6.9
8.2
—
—
—
0
0
12
60
2.03
1.39
1.0
1.1
—
—
—
0
0
12
60
2.03
1.39
1.0
1.1
—
—
—
0
0
9
41
2.22
1.37
2.8
1.9
—
—
—
0
0
9
41
2.22
1.37
1.2
1.1
—
—
—
0
0
404
3882
1.40
1.35
5.9
5.8
2.72
2.73
mmol/l
0.15
387
3630
30
201
1.53
1.33
2.5
2.4
—
—
—
0
0
191
1690
1.23
1.33
3.4
3.6
6.27
6.18
ph
0.48
104
970
15
83
1.84
1.33
3.5
2.6
10.05
8.37
pmol/l
0.41
15
83
39
277
1.45
1.32
1.8
1.5
1.14
1.44
g/l
0.58
34
256
9
43
2.11
1.31
1.3
1.3
—
—
—
0
0
81
651
1.30
1.28
3.6
2.9
1.43
2.34
e6/l
1.25
42
318
8
35
2.31
1.27
2.1
1.1
110.25
103.20
pmol/l
—
8
35
8
35
2.31
1.27
1.0
1.2
—
—
—
0
0
141
1214
1.24
1.26
4.4
4.1
0.02
0.01
estimate
0.09
64
431
346
3265
1.26
1.26
22.6
19.2
13.62
13.61
%
0.04
340
3238
6
25
2.42
1.24
1.2
1.3
—
—
—
0
0
9
45
2.02
1.24
1.2
1.1
—
—
—
0
0
93
768
1.27
1.20
3.7
3.8
476.51
284.63
ng/l
0.39
68
577
6
26
2.32
1.19
1.0
1.2
11.00
8.19
mm/h
—
6
26
59
459
1.33
1.18
2.4
2.9
7.57
7.74
umol/l
0.02
50
412
410
3963
1.39
1.18
16.7
13.8
—
—
—
0
0
398
3830
1.34
1.18
5.2
5.1
4.63
4.67
mmol/l
0.39
378
3585
47
353
1.37
1.18
1.6
1.4
—
—
—
0
0
10
50
2.02
1.17
1.5
1.2
—
—
—
0
0
13
72
1.83
1.16
3.2
2.9
—
—
—
0
0
48
365
1.35
1.12
5.6
5.2
0.00
0.23
%
—
10
96
381
3651
1.28
1.12
6.8
6.3
39.09
39.15
mmol/mol
0.05
363
3447
38
279
1.40
1.10
1.1
1.3
72.68
127.47
u/ml
0.60
12
126
12
66
1.84
1.10
1.3
1.3
0.58
0.57
nmol/l
0.06
12
59
5
21
2.40
1.09
1.2
1.1
5.71
6.84
mmol/l
—
5
21
150
1320
1.20
1.07
4.4
4.1
7.97
9.85
mg/mmol
0.35
97
816
42
316
1.36
1.06
1.7
1.5
—
—
—
0
0
38
282
1.38
1.04
2.7
2.4
9.44
19.03
au/ml
—
7
21
12
68
1.79
1.01
1.4
1.3
—
—
—
0
0
61
490
1.28
0.99
1.6
1.5
—
—
—
0
0
9
49
1.85
0.99
1.4
1.4
—
—
—
0
0
15
92
1.65
0.98
2.1
2.4
39.12
110.49
ug/min
—
10
51
395
3818
1.28
0.96
5.2
5.0
1.47
1.49
mmol/l
0.27
375
3556
0
32
0.00
0.95
0.0
1.5
—
1.30
—
0
25
22
150
1.49
0.95
1.1
1.3
—
—
—
0
0
40
305
1.34
0.94
1.2
1.2
—
—
—
0
0
10
55
1.84
0.92
1.2
1.1
—
—
—
0
0
122
1067
1.20
0.92
4.6
4.2
—
—
—
0
0
35
263
1.36
0.91
2.9
3.1
202.14
200.38
ng/l
0.01
35
241
132
1165
1.19
0.90
1.7
1.6
19.64
20.92
nmol/l
0.45
110
985
45
353
1.31
0.88
5.5
4.9
0.10
0.16
%
—
10
100
78
655
1.23
0.88
3.4
3.2
0.79
0.77
ug/l
0.03
55
418
153
1371
1.18
0.87
3.5
3.3
7.20
7.56
mmol/l
0.56
138
1168
12
72
1.68
0.86
1.1
1.3
157.86
174.43
au/ml
—
7
24
128
1134
1.18
0.83
1.4
1.4
—
—
—
0
0
426
4176
1.38
0.78
28.2
23.6
247.62
251.66
e9/l
0.66
421
4111
0
27
0.00
0.77
0.0
4.7
—
16.55
—
0
27
27
201
1.37
0.76
1.3
1.2
—
—
—
0
0
415
4056
1.30
0.75
13.3
12.0
24.95
25.84
u/l
0.65
409
3952
5
24
2.10
0.74
2.2
1.5
108.80
85.02
ng/l
—
5
24
426
4179
1.36
0.74
28.2
23.6
4.50
4.49
e12/l
0.15
421
4104
426
4180
1.36
0.73
28.3
23.7
6.67
6.65
e9/l
0.05
419
4102
9
57
1.59
0.71
1.2
1.2
126.78
367.50
pmol/l
—
9
52
44
357
1.26
0.70
5.3
4.6
0.70
0.61
%
—
10
111
7
117
0.59
0.69
1.4
1.3
—
—
—
0
0
7
42
1.68
0.68
1.7
2.4
—
—
—
0
0
15
102
1.49
0.68
1.5
1.4
775.40
155.27
e6/l
—
10
81
142
1290
1.15
0.66
3.7
3.4
49.11
55.00
mg/l
0.17
95
836
5
28
1.79
0.66
1.0
1.7
30.86
41.86
%
—
5
28
46
378
1.24
0.66
5.4
4.7
0.64
1.10
%
0.80
11
126
12
78
1.55
0.66
2.8
1.3
0.78
0.89
nmol/l
0.25
12
64
13
87
1.51
0.64
1.4
1.4
—
—
—
0
0
125
1129
1.15
0.63
3.1
3.0
—
0.08
—
0
25
196
1824
1.13
0.63
2.8
2.5
77.56
77.69
nmol/l
0.02
183
1651
120
1081
1.15
0.63
6.0
5.5
2.21
2.52
ug/l
0.29
109
978
12
79
1.53
0.63
1.2
1.3
305.14
255.67
u/ml
—
7
41
17
121
1.42
0.63
2.4
2.4
10.26
11.56
mg/l
0.36
17
116
108
966
1.16
0.63
4.2
4.1
1.02
1.02
kg/l
0.03
74
637
74
642
1.18
0.62
1.6
1.7
—
—
—
0
0
16
113
1.43
0.62
1.5
3.3
1.23
1.97
ratio
—
10
63
113
1016
1.15
0.61
2.5
2.1
3.04
2.94
mg/l
0.09
95
887
91
805
1.16
0.61
1.8
1.7
467.57
28190357.08
pmol/l
0.77
69
674
16
114
1.42
0.59
1.1
1.2
—
—
—
0
0
140
1280
1.14
0.59
2.3
2.4
52.87
65.33
u/l
1.63
131
1189
12
81
1.49
0.57
1.3
1.2
—
—
—
0
0
6
37
1.63
0.55
1.2
1.1
—
—
—
0
0
83
737
1.15
0.54
1.7
1.9
—
—
—
0
0
14
100
1.41
0.52
1.4
1.3
199.33
15.78
e6/l
—
9
77
6
40
1.51
0.51
1.7
1.3
—
—
—
0
0
201
1892
1.11
0.51
3.7
3.0
114.19
114.94
ug/l
0.02
189
1775
17
127
1.35
0.50
8.0
9.2
—
—
—
0
0
17
127
1.35
0.50
1.1
1.3
—
—
—
0
0
10
67
1.50
0.50
1.0
1.1
—
—
—
0
0
135
1245
1.12
0.50
4.5
3.9
7.40
7.40
ph
0.11
102
877
373
3638
1.15
0.49
4.4
4.3
1.27
1.28
mmol/l
0.01
349
3366
7
46
1.53
0.48
2.7
3.1
—
—
—
0
0
47
403
1.19
0.47
3.4
3.4
5.76
5.79
kpa
0.06
47
392
5
82
0.61
0.46
1.2
1.6
—
—
—
0
0
169
1587
1.10
0.44
3.2
3.2
—
—
—
0
0
90
817
1.13
0.43
2.9
2.7
2.44
2.45
mmol/l
0.31
83
735
21
167
1.27
0.42
1.1
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.0
—
0.16
—
0
5
0
17
0.00
0.40
0.0
1.0
—
0.19
—
0
5
8
61
1.32
0.39
1.5
1.9
—
—
—
0
0
128
1194
1.10
0.38
3.5
3.3
0.00
0.07
estimate
0.52
50
375
27
322
0.83
0.38
1.6
1.8
3.72
3.50
mmol/l
0.48
17
244
18
143
1.27
0.37
1.6
2.8
—
—
—
0
0
5
79
0.63
0.36
1.2
1.5
1.15
1.33
mm
—
5
61
5
80
0.62
0.35
2.8
2.9
37.80
33.42
umol/l
—
5
73
5
80
0.62
0.35
1.2
1.5
—
—
—
0
0
10
134
0.74
0.35
1.0
1.1
—
0.75
—
0
19
10
73
1.38
0.35
3.3
3.4
3.52
4.40
e9/l
—
10
73
45
397
1.15
0.34
1.8
1.5
—
—
—
0
0
178
1695
1.08
0.34
1.9
1.9
1.30
1.36
mmol/l
0.45
154
1427
15
188
0.79
0.34
1.3
1.3
—
—
—
0
0
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
7
57
1.23
0.29
1.1
1.3
—
67.54
—
0
5
45
404
1.13
0.28
3.8
3.4
7.38
7.38
ph
0.23
24
228
8
63
1.27
0.28
1.0
1.2
10.51
85.06
mu/l
—
8
57
23
196
1.18
0.27
2.0
2.0
9.78
6.22
iu/ml
—
5
56
130
1233
1.08
0.27
3.4
3.0
—
—
—
0
0
35
311
1.14
0.26
3.5
3.7
87.43
80.95
ng/l
0.26
26
275
40
362
1.12
0.23
1.5
1.7
—
—
—
0
0
5
39
1.29
0.23
1.0
1.2
280.40
276.43
mosm/kgh2o
—
5
30
38
343
1.12
0.23
5.8
4.2
7.38
7.35
ph
1.08
25
247
11
88
1.26
0.22
1.3
1.7
—
—
—
0
0
12
146
0.82
0.22
1.1
1.1
0.79
0.91
g/l
1.20
12
146
5
41
1.22
0.22
1.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
0.75
—
0
5
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
45.11
—
0
10
0
10
0.00
0.21
0.0
1.0
—
8.79
—
0
5
12
98
1.23
0.21
3.2
3.1
59.61
59.00
%
0.07
12
98
5
43
1.16
0.21
1.2
1.3
—
—
—
0
0
67
627
1.08
0.20
2.1
1.7
1276.02
1221.11
nmol/l
0.12
43
482
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
28
312
0.89
0.20
1.4
2.5
12.05
7.21
ug/l
0.45
22
276
6
52
1.16
0.19
14.5
7.3
7.08
7.23
mmol/l
—
6
43
6
53
1.13
0.18
2.0
2.3
33.17
33.36
pg
—
6
53
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
7
58
1.21
0.18
2.4
2.9
—
—
—
0
0
17
195
0.87
0.18
1.3
1.8
—
—
—
0
0
12
142
0.84
0.17
1.1
1.1
1.50
1.57
g/l
0.56
12
142
45
417
1.09
0.17
1.5
1.5
—
—
—
0
0
14
122
1.15
0.14
3.5
3.7
374.63
271.04
mg/l
—
8
50
41
386
1.07
0.12
3.5
3.4
2.19
1.94
mmol/l
0.14
36
328
15
167
0.89
0.11
5.8
3.6
—
—
—
0
0
16
144
1.12
0.10
1.1
1.5
—
—
—
0
0
20
218
0.91
0.10
2.5
2.5
0.63
0.62
%
0.08
20
218
5
44
1.14
0.10
1.0
1.8
—
—
—
0
0
6
54
1.11
0.09
1.5
1.2
—
—
—
0
0
16
146
1.10
0.08
1.1
1.5
—
—
—
0
0
16
146
1.10
0.08
1.1
1.5
—
—
—
0
0
18
195
0.92
0.08
1.5
1.4
0.36
0.34
mg/l
—
9
80
26
244
1.07
0.08
3.3
2.9
133.27
128.45
g/l
0.54
26
239
16
147
1.09
0.07
1.1
1.5
—
—
—
0
0
8
94
0.85
0.06
4.1
4.5
—
—
—
0
0
47
453
1.04
0.06
3.8
3.0
1.80
1.82
%
0.05
42
419
268
2661
1.02
0.04
3.1
3.3
44.59
46.17
u/l
0.10
253
2515
40
389
1.03
0.03
2.7
2.3
31.48
34.67
u/l
0.41
31
328
40
411
0.97
0.03
4.3
4.2
3.15
18.98
ug/l
0.90
33
341
23
222
1.04
0.02
1.0
1.1
—
—
—
0
0
50
491
1.02
0.02
1.3
1.4
—
—
—
0
0
177
1760
1.01
0.01
2.3
2.0
97.43
97.66
pmol/l
0.02
95
897
17
177
0.96
0.01
3.4
3.4
24.50
25.17
mmol/l
0.46
17
172
13
136
0.95
0.00
1.2
1.5
—
—
—
0
0
10
96
1.04
0.00
1.9
1.9
—
—
—
0
0
33
328
1.01
0.00
2.2
2.2
6.04
6.14
ph
0.24
24
223
34
338
1.01
0.00
3.5
3.2
72.00
71.69
e9/l
0.02
26
257
5
56
0.89
-0.00
1.4
1.5
—
—
—
0
0
5
56
0.89
-0.00
1.4
1.5
—
—
—
0
0
5
56
0.89
-0.00
1.4
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
0.54
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
1.80
—
0
6
0
6
0.00
-0.00
0.0
3.5
—
48.67
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
7.0
—
8.83
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
52.00
—
0
8
0
6
0.00
-0.00
0.0
1.5
—
40.00
—
0
6
0
7
0.00
-0.00
0.0
2.0
—
15.61
—
0
7
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
7.00
—
0
7
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
56
0.89
-0.00
1.4
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_CONNSOFT_NOS – Benign neoplasm: Connective and other soft tissue, unspecified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).